US20180327770A1 - Guayule with increased rubber production and yield - Google Patents
Guayule with increased rubber production and yield Download PDFInfo
- Publication number
- US20180327770A1 US20180327770A1 US15/975,912 US201815975912A US2018327770A1 US 20180327770 A1 US20180327770 A1 US 20180327770A1 US 201815975912 A US201815975912 A US 201815975912A US 2018327770 A1 US2018327770 A1 US 2018327770A1
- Authority
- US
- United States
- Prior art keywords
- paaos
- guayule
- altered
- rubber
- pnd6
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241001495453 Parthenium argentatum Species 0.000 title claims abstract description 261
- LOVYCUYJRWLTSU-UHFFFAOYSA-N 2-(3,4-dichlorophenoxy)-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC=C(Cl)C(Cl)=C1 LOVYCUYJRWLTSU-UHFFFAOYSA-N 0.000 title claims abstract description 205
- 230000001965 increasing effect Effects 0.000 title claims abstract description 23
- 238000010092 rubber production Methods 0.000 title description 11
- 229920001971 elastomer Polymers 0.000 claims abstract description 166
- 239000005060 rubber Substances 0.000 claims abstract description 166
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 150000001413 amino acids Chemical class 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 60
- 108020004705 Codon Proteins 0.000 claims description 41
- 108020004414 DNA Proteins 0.000 claims description 41
- 150000007523 nucleic acids Chemical class 0.000 claims description 35
- 238000006467 substitution reaction Methods 0.000 claims description 32
- 230000004075 alteration Effects 0.000 claims description 31
- 102000039446 nucleic acids Human genes 0.000 claims description 30
- 108020004707 nucleic acids Proteins 0.000 claims description 30
- 230000035772 mutation Effects 0.000 claims description 25
- 238000012360 testing method Methods 0.000 claims description 17
- 108091093088 Amplicon Proteins 0.000 claims description 15
- 239000001472 potassium tartrate Substances 0.000 claims description 15
- 108091081024 Start codon Proteins 0.000 claims description 9
- 230000027455 binding Effects 0.000 claims description 9
- 239000003471 mutagenic agent Substances 0.000 claims description 8
- 231100000707 mutagenic chemical Toxicity 0.000 claims description 8
- 230000014621 translational initiation Effects 0.000 claims description 7
- 238000012217 deletion Methods 0.000 claims description 5
- 230000037430 deletion Effects 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 238000002944 PCR assay Methods 0.000 claims description 4
- 238000003205 genotyping method Methods 0.000 claims description 4
- 230000003505 mutagenic effect Effects 0.000 claims description 3
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000004077 genetic alteration Effects 0.000 abstract description 3
- 231100000118 genetic alteration Toxicity 0.000 abstract description 3
- 239000000090 biomarker Substances 0.000 abstract description 2
- 101000899492 Parthenium argentatum Allene oxide synthase Proteins 0.000 description 181
- 241000196324 Embryophyta Species 0.000 description 163
- 235000001014 amino acid Nutrition 0.000 description 81
- 210000004027 cell Anatomy 0.000 description 67
- 229940024606 amino acid Drugs 0.000 description 61
- 108090000623 proteins and genes Proteins 0.000 description 60
- 210000001519 tissue Anatomy 0.000 description 54
- 102000040430 polynucleotide Human genes 0.000 description 50
- 108091033319 polynucleotide Proteins 0.000 description 50
- 239000002157 polynucleotide Substances 0.000 description 50
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 47
- 102000004169 proteins and genes Human genes 0.000 description 34
- 235000018102 proteins Nutrition 0.000 description 32
- 125000003729 nucleotide group Chemical group 0.000 description 29
- 239000002773 nucleotide Substances 0.000 description 28
- 230000014509 gene expression Effects 0.000 description 27
- 239000013604 expression vector Substances 0.000 description 23
- 239000013612 plasmid Substances 0.000 description 21
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 19
- 108020004635 Complementary DNA Proteins 0.000 description 19
- 230000000295 complement effect Effects 0.000 description 18
- 238000010804 cDNA synthesis Methods 0.000 description 17
- 239000002299 complementary DNA Substances 0.000 description 17
- 244000043261 Hevea brasiliensis Species 0.000 description 16
- 238000011529 RT qPCR Methods 0.000 description 15
- 238000013518 transcription Methods 0.000 description 15
- 230000035897 transcription Effects 0.000 description 15
- 229920003052 natural elastomer Polymers 0.000 description 14
- 229920001194 natural rubber Polymers 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 229920001184 polypeptide Polymers 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 13
- 239000013598 vector Substances 0.000 description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 230000012010 growth Effects 0.000 description 11
- 230000009466 transformation Effects 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000000523 sample Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 108091033409 CRISPR Proteins 0.000 description 7
- 108091030071 RNAI Proteins 0.000 description 7
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 230000030279 gene silencing Effects 0.000 description 7
- 230000009368 gene silencing by RNA Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- 241000589158 Agrobacterium Species 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- 108091005461 Nucleic proteins Proteins 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 108010017070 Zinc Finger Nucleases Proteins 0.000 description 6
- 229930002875 chlorophyll Natural products 0.000 description 6
- 235000019804 chlorophyll Nutrition 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 230000002018 overexpression Effects 0.000 description 6
- 230000000243 photosynthetic effect Effects 0.000 description 6
- 239000002689 soil Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 108020005544 Antisense RNA Proteins 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 210000003463 organelle Anatomy 0.000 description 5
- 230000009261 transgenic effect Effects 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 4
- 238000010354 CRISPR gene editing Methods 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000006870 ms-medium Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- PBLQSFOIWOTFNY-UHFFFAOYSA-N 3-methylbut-2-enyl 4-methoxy-8-(3-methylbut-2-enoxy)quinoline-2-carboxylate Chemical compound C1=CC=C2C(OC)=CC(C(=O)OCC=C(C)C)=NC2=C1OCC=C(C)C PBLQSFOIWOTFNY-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 230000009946 DNA mutation Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229930191978 Gibberellin Natural products 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- 125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 101100112138 Mesembryanthemum crystallinum PPCA gene Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 101150012928 PPC1 gene Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 101100028851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PCK1 gene Proteins 0.000 description 3
- 238000010459 TALEN Methods 0.000 description 3
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 102000044159 Ubiquitin Human genes 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- -1 aliphatic amino acids Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000003184 complementary RNA Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- IXORZMNAPKEEDV-UHFFFAOYSA-N gibberellic acid GA3 Natural products OC(=O)C1C2(C3)CC(=C)C3(O)CCC2C2(C=CC3O)C1C3(C)C(=O)O2 IXORZMNAPKEEDV-UHFFFAOYSA-N 0.000 description 3
- 239000003448 gibberellin Substances 0.000 description 3
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 229940027257 timentin Drugs 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 238000011179 visual inspection Methods 0.000 description 3
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 2
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 2
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 108010025188 Alcohol oxidase Proteins 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 0 C(C1)C2=C1*CC2 Chemical compound C(C1)C2=C1*CC2 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 241001508381 Subterranean clover stunt virus Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010805 cDNA synthesis kit Methods 0.000 description 2
- 229920003211 cis-1,4-polyisoprene Polymers 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000006353 environmental stress Effects 0.000 description 2
- 239000012632 extractable Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- LXJXRIRHZLFYRP-UHFFFAOYSA-N glyceraldehyde 3-phosphate Chemical compound O=CC(O)COP(O)(O)=O LXJXRIRHZLFYRP-UHFFFAOYSA-N 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 238000003976 plant breeding Methods 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011533 pre-incubation Methods 0.000 description 2
- 238000000899 pressurised-fluid extraction Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 230000005068 transpiration Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- MAKBWIUHFAVVJP-HAXARLPTSA-N (2R,3S)-pentane-1,2,3,4-tetrol phosphoric acid Chemical compound OP(O)(O)=O.CC(O)[C@H](O)[C@H](O)CO MAKBWIUHFAVVJP-HAXARLPTSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- VQQXDBPNEPNNNS-UHFFFAOYSA-N C(C1)C2=C1CCC2 Chemical compound C(C1)C2=C1CCC2 VQQXDBPNEPNNNS-UHFFFAOYSA-N 0.000 description 1
- QCMYYKRYFNMIEC-UHFFFAOYSA-N COP(O)=O Chemical class COP(O)=O QCMYYKRYFNMIEC-UHFFFAOYSA-N 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001515826 Cassava vein mosaic virus Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 240000002319 Citrus sinensis Species 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101100125027 Dictyostelium discoideum mhsp70 gene Proteins 0.000 description 1
- 101000686777 Escherichia phage T7 T7 RNA polymerase Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 1
- QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 1
- LKOAAMXDJGEYMS-ZPFDUUQYSA-N Glu-Met-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LKOAAMXDJGEYMS-ZPFDUUQYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- 101150031823 HSP70 gene Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- WZOGEMJIZBNFBK-CIUDSAMLSA-N His-Asp-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O WZOGEMJIZBNFBK-CIUDSAMLSA-N 0.000 description 1
- SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 1
- YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- 125000000010 L-asparaginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 1
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 description 1
- 125000002061 L-isoleucyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](C([H])([H])[H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- 125000002435 L-phenylalanyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 1
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 1
- 125000003798 L-tyrosyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
- KTOIECMYZZGVSI-BZSNNMDCSA-N Leu-Phe-His Chemical compound C([C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=CC=C1 KTOIECMYZZGVSI-BZSNNMDCSA-N 0.000 description 1
- 108010062166 Lys-Asn-Asp Proteins 0.000 description 1
- BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 1
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 101710104378 Putative malate oxidoreductase [NAD] Proteins 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- VQBLHWSPVYYZTB-DCAQKATOSA-N Ser-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N VQBLHWSPVYYZTB-DCAQKATOSA-N 0.000 description 1
- CDVFZMOFNJPUDD-ACZMJKKPSA-N Ser-Gln-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CDVFZMOFNJPUDD-ACZMJKKPSA-N 0.000 description 1
- 241001575928 Siler Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 101710156615 Sucrose synthase 1 Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
- 108091028113 Trans-activating crRNA Proteins 0.000 description 1
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- SWSUXOKZKQRADK-FDARSICLSA-N Trp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SWSUXOKZKQRADK-FDARSICLSA-N 0.000 description 1
- KWKJGBHDYJOVCR-SRVKXCTJSA-N Tyr-Ser-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O KWKJGBHDYJOVCR-SRVKXCTJSA-N 0.000 description 1
- AFWXOGHZEKARFH-ACRUOGEOSA-N Tyr-Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 AFWXOGHZEKARFH-ACRUOGEOSA-N 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 238000009614 chemical analysis method Methods 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 101150052825 dnaK gene Proteins 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 238000012246 gene addition Methods 0.000 description 1
- JLJLRLWOEMWYQK-OBDJNFEBSA-N gibberellin A1 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@@]2(OC3=O)[C@H]1[C@@]3(C)[C@@H](O)CC2 JLJLRLWOEMWYQK-OBDJNFEBSA-N 0.000 description 1
- OXFPYCSNYOFUCH-KQBHUUJHSA-N gibberellin A20 Chemical compound C([C@H]12)C[C@@](C3)(O)C(=C)C[C@@]13[C@@H](C(O)=O)[C@@H]1[C@]3(C)C(=O)O[C@@]12CCC3 OXFPYCSNYOFUCH-KQBHUUJHSA-N 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 108010040856 glutamyl-cysteinyl-alanine Proteins 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 230000019516 nonphotochemical quenching Effects 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 108010017425 phloem lectin Proteins 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000012260 resinous material Substances 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 108010067930 structure-specific endonuclease I Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01092—Hydroperoxide dehydratase (4.2.1.92)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L7/00—Compositions of natural rubber
- C08L7/02—Latex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- This invention relates to altered guayule plants that grow larger and produce more rubber than non-altered guayule plants, when grown under the same conditions.
- the altered guayule contain the cDNA sequence of Parthenium argentatum Allene oxide synthase (PaAos) in the reverse complement orientation under control of a heterologous promoter which reduces the production of PaAos via RNAi.
- PaAos Parthenium argentatum Allene oxide synthase
- Kits for identifying such altered guayule, methods for identify the altered guayule, and methods of increasing rubber yield in guayule via reducing PaAos translation are also included.
- Natural rubber is synthesized by more than 2,500 plant species (Cornish, et al., J. Nat. Rubber Research 8:275-285 (1993); Cornish, K., Phytochemistry 57:1123-1134 (2001)). Rubber is produced by these plants as a secondary metabolite with no clear indication of its function in plant cells. Possible reasons on why these species synthesize rubber are to defend themselves against pathogens and insect attacks, repair tissue damages caused by mechanical wounding and protect cell damage induced by environmental stresses (Demel, et al., Biochim. Biophys. Acta. 1375:36-42 (1998); Tangpakdee and Tanaka, J. Rubber Res. 1:14 (1998); Vereyken, et al., Biochim. Biophys.
- the Hevea tree is the main source of natural rubber but concerns exist as it is limited geographically to tropical climates, mainly in Southeast Asia, is susceptible to diseases, and produces rubber that causes allergic reactions. Clearly, an alternative source for the production of natural rubber is very important to reduce economic risk and safeguard human health.
- guayule Parthenium argentatum, Gray
- guayule Parthenium argentatum, Gray
- the majority of rubber synthesis in guayule occurs during the cold season.
- Guayule synthesizes rubber within subcellular organelles called rubber particles (Archer and Audley, Bot. J. Linnean Soc. 94:181-196 (1987)) stored in the parenchyma cells of stembark tissues (Gilliland, M.
- Natural rubber synthesis is initiated by the action of allylic pyrophosphates initiators (Cornish and Siler, J. Plant Physiol., 301-305 (1995)), usually farnesyl pyrophosphate (FPP).
- FPP farnesyl pyrophosphate
- the monomer isopentenyl-pyrophosphate (IPP), produced by the mevalonic acid pathway (MEV) in the cytosol and the methylerythritol phosphate (MEP) pathway in the plastid elongates the rubber chain.
- Rubber synthesis is mediated by rubber transferases requiring magnesium ions as cofactor (Da Costa, et al., Phytochemistry 67(15): 1621-1628 (2006)).
- the proposed model for the structure of rubber particles consists mostly of hydrophobic cis-polyisoprene units (natural rubber) encapsulated inside a protein and phospholipid surface monolayer (Nawamawat, et al., Colloids and Surfaces A: Physicochemical and Engineering Aspects, 390:157-166 (2011); Sansatsadeekul, et al., J. Biosci. and Bioeng, 111:628-634 (2011)).
- the phospholipids serve to stabilize and solubilize the otherwise insoluble (rubber) product.
- Guayule rubber particles include several proteins (Whalen, et al., Development of crops to produce industrially useful natural rubber .
- the mutation in the altered guayule can be one or more of (i) an alteration in a Parthenium argentatum Allene oxide synthase (PaAos) codon encoding an amino acid to a stop codon, (ii) an alteration of PaAos' translation initiation codon to another codon, (iii) an alteration in PaAos ribosome binding site's sequence, (iv) an alteration in one or more PaAos splice site codons, (v) a deletion of part or all of PaAos' sequence, (vi) an insertion of DNA into PaAos, and (vii) an alteration in one or more PaAos DNA codon sequences to encode a non-conservative amino acid.
- PaAos Parthenium argentatum Allene oxide synthase
- each of these mutations reduces the altered PaAos' functionality compared to the amount of PaAos functionality in a non-altered guayule and that the reduced PaAos functionality causes the altered guayule to produce an increased amount of rubber compared to the amount of rubber produced by the non-altered guayule.
- the alteration of one or more PaAos DNA codon sequences to encode a non-conservative amino acid occurs at amino acids located at 318, 332, 336, 339, 359, 408, 411, and 459 with PaAos' sequence (see SEQ ID NO: 10, 13, and 15).
- amino acids being changed to non-conservative amino acids are D318, S332, E336, R339, S359, I408, S411, and/or L459.
- non-conservative amino acid substitutions are not N318, V408 and/or W459. It is another object of this invention to have an altered cell, germplasm, and an altered seed of the altered guayule, each containing the mutation.
- the mutated PaAos contains at least one of (i) an alteration of a PaAos codon encoding an amino acid to a stop codon, (ii) an alteration of PaAos' translation initiation codon to another codon, (iii) an alteration of PaAos ribosome binding site's sequence, (iv) an alteration of one or more PaAos splice site codons, (v) a deletion of part or all of PaAos' sequence, (vi) an insertion of DNA into PaAos, and (vii) an alteration of one or more PaAos codon sequences to encode a non-conservative amino acid.
- the alteration of one or more PaAos codon sequences to encode a non-conservative amino acid occurs at amino acids located at 318, 332, 336, 339, 359, 408, 411, and 459 with PaAos' sequence (see SEQ ID NO: 10, 13, and 15).
- Another object of this invention is that the non-conservative amino acid substitutions are not N318, V408 and/or W459. It is another object of this invention to have an altered cell, germplasm, and an altered seed of the altered guayule produced by this method and each containing the mutation.
- PaAos with low functionality contains at least one amino acid selected from group of N318, V408, W459, conservative amino acids substitutions thereof, and non-conservative amino acid substitutions at S332, E336, R339, S359, and S411.
- the method involves contacting the PaAos from the test guayule with monoclonal antibodies that binds to PaAos having the above mentioned amino acids, and determining if the monoclonal antibodies bind to the PaAos from the test guayule, where binding indicates the presence of the high rubber producing PaAos and no binding indicates the present of the low rubber producing PaAos.
- the invention involves obtaining nucleic acids from the test guayule, performing a PCR assay with the obtained nucleic acids, a label, and primer sets SEQ ID NOs: 22 and 23, and SEQ ID NOs: 24 and 25, or similar sequences that encode conservative amino acid substitutions, and determining if an amplicon is generated; such that when an amplicon is produced, then the test guayule contains a PaAos nucleic acid sequence that encodes PaAos having amino acids N318, V408 and/or W459, or one or more of the conservative amino acid substitution at these positions, and/or non-conservative amino acid substitutions at S332, E336, R339, S359, and S411, and the test guayule is a high rubber producing guayule.
- FIG. 1 shows the design of the plasmids used in Example 1 for the overexpression of PaAos (pND6-Aos), silencing of PaAos (pND6-AosiL), and for the control plasmid (pND6).
- Each expression vector features the NPTII gene to confer kanamycin resistance for selection, and the control plasmid contains the GUS ( ⁇ -glucuronidase) reporter gene instead of PaAos or a portion of PaAos in reverse complementary orientation.
- GUS ⁇ -glucuronidase
- FIG. 2 shows the primers used in the qRT-PCR, PCR reaction conditions, and the expected amplicon product size to determine RNA expression in the genetically altered guayule.
- Amplicon (mRNA product) PaAos OE is derived from plants transformed with pND6-Aos (Aos overexpression).
- Amplicon (mRNA product) PaAos RNAi is derived from plants transformed with pND6-AosiL (Aos silencing).
- Amplicon (mRNA product) 18S is from 18S ribosome RNA.
- Amplicon (mRNA product) PaAos is for wild-type guayule plants with intact PaAos gene.
- FIG. 3 provides size and weight measurements of the four types of guayule plants grown under different conditions in growth chambers. Plants are initially transferred to soil from tissue culture media and grown under greenhouse conditions for one month. Following, plants are moved to controlled-temperature growth chamber conditions under 27° C. (16 h)/25° C. (8 h) and at 27° C. (16 h)/10° C. (8 h).
- the four type of guayule plants are wild-type (G7-11.1 and G7-11.2), guayule transformed with the empty expression vector pND6 (pND6-10, pND6-12, pND6-35), guayule transformed with pND6-AosiL for silencing PaAos via RNAi (pND6-AosiL 7-2 , pND6-AosiL 8-1 , pND6-AosiL 9-16 , pND6-AosiL 12-1 ,), and guayule transformed with pND6-Aos to overexpress PaAos (pND6-Aos 4-1 , pND6-Aos 4-2 , pND6-Aos 5-1 , pND6-Aos 7-1 ,) at 2 months old.
- G7-11 is a breeder's nomenclature for what later became the USDA publicly released guayule Germplasm line AZ-2 (Reg. No. GP-9; PI 599676).
- the biomass of the shoot (leaves plus stems) and root are weighed in 2 months old guayule plants grown in growth chambers under 27° C. (16 h)/25° C. (8 h) and at 27° C. (16 h)/10° C. (8 h).
- the asterisks, (*), (**) and (***) indicate significant difference in comparison to (non-altered) G7-11 at p>0.05, 0.005 and 0.0005, respectively.
- FIG. 4 shows SPAD values indicating leaf chlorophyll concentration (“SPAD units”) for wild-type guayule (G7-11), guayule transformed with the empty expression vector (pND6); guayule transformed with pND6-Aos (Oe), and guayule transformed with pND6-AosiL (RNAi) grown at 27° C. (16 h)/25° C. (8 h) or 27° C. (16 h)/10° C. (8 h).
- SPAD units leaf chlorophyll concentration
- FIG. 5 shows the number of branches and stem diameter of 2 months old genetically altered guayule (pND6-AosiL and pND6-Aos lines), non-altered guayule (G7-11) and empty vector control guayule (pND6) plants grown in growth chambers at 27° C. (16 h)/25° C. (8 h) or at 27° C. (16 h)/10° C. (8 h).
- pND6-AosiL genotypes have larger number of stems than the non-altered and empty vector controls. Additionally, the mature stembark tissues in pND6-AosiL have significantly thicker diameter (ranging from 35% to 54%) under both 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h).
- FIG. 6 shows results from gel permeation chromatography for elution of cyclohexane extractables from transformed and non-altered guayule plant lines.
- the natural rubber molecular weight is calculated using Astra software for three pND6-AosiL transformed guayule plants, three pND6-Aos transformed guayule plants, two pND6 transformed guayule plants, and non-altered guayule G7-11.
- the error bars represent 3 different plants with 3 technical replicates.
- FIG. 7 shows the relative expression of PaAos in guayule line G7-11, guayule line W6 549 (“W6549”), and guayule line PI 478652 (“478652”).
- FIG. 8A , FIG. 8B , and FIG. 8C show single nucleotide polymorphisms (SNPs) in PaAos coding sequence for guayule cultivars W6 549 (“W6549”; SEQ ID NO: 12), G7-11 (SEQ ID NO: 9), and PI 478652 (“478652”; SEQ ID NO: 14).
- the SNPs are contained in boxes.
- FIG. 9 shows an alignment of PaAos amino acid sequences obtained from guayule cultivars W6 549 (“W6549”; SEQ ID NO: 13), PI 478652 (“478652”; SEQ ID NO: 15) and G7-11 (SEQ ID NO: 10).
- the boxes highlight the different amino acids in the cultivars.
- This invention involves the discovery that a reduction in the amount of functional PaAos in guayule results in an increase in the amount of rubber produced. Further, different cultivars of guayule, having different DNA and amino acid sequences for PaAos and PaAos, respectively, produce different amounts of rubber. As such, one can distinguish between guayule cultivars that are “high” rubber producers and “low” rubber producers based on the differences in the DNA and/or amino acid sequence of PaAos and/or PaAos.
- guayule cultivar W6 549 has the lowest average rubber content (%) and guayule cultivar PI 478652 has the highest average rubber content, among the tested cultivars.
- PaAos from both cultivars have slight differences in DNA sequences which, along with the differences in the amino acid sequences, can be used to determine if any particular cultivar is a high or low rubber producer.
- Any guayule that produces PaAos with conservative amino acid changes to SEQ ID NO: 15 is a high rubber producing guayule; any guayule that produces PaAos with conservative amino acid changes to SEQ ID NO: 13 is a low rubber producing guayule.
- one screening for guayule with PaAos with the similar (or lower) level of functionality as guayule cultivar PI 478652's PaAos would identify a high rubber producing guayule; whereas screening for guayule with PaAos with a higher level of functionality would identify a low rubber producing guayule.
- this invention also involves increasing a guayule's rubber production by reducing the amount of functional PaAos present in the genetically altered guayule (compared to the amount of functional PaAos present in non-altered guayule).
- the genetically altered guayule has a mutation in PaAos, such as, a null mutation which results in (i) no protein is produced, (ii) a truncated protein is produced which has no functionality, or (iii) a full-length protein is produced which has no functionality. Other mutations simply reduce the functionality (activity) of PaAos.
- Non-limiting examples of mutations that reduce or eliminate PaAos functionality include (i) changing a codon encoding an amino acid to a stop codon (see Table 1 supra for the sequence of stop codons), (ii) changing the translation initiation codon (ATG) to any other codon to disrupt protein translation, (iii) changing a ribosome binding site's sequence to disrupt protein translation, (iv) changing one or more splice site codons to alter protein sequence, (v) deleting some or all of the gene's DNA sequence, (vi) inserting DNA into the gene, and (vii) changing one or more DNA codon sequences to encode non-conservative amino acids.
- nucleotides 34-36 encode ATG, the translation initiation codon for G7-11 guayule.
- nucleotides 1-3 of SEQ ID NOs: 12 and 14 encode ATG, the translation initiation codon for cultivars PI 478652 and W6549, respectfully.
- a change in the nucleotide sequence of the equivalent codon in any other guayule would have the same result.
- non-conservative amino acid substitutions at D318, S332, E336, R339, S359, I408, S411, and/or L459 result in PaAos with reduced functionality.
- isolated refers to material that is substantially or essentially free from components that normally accompany the material in its native state or when the material is produced.
- purity and homogeneity are determined using analytical chemistry techniques such as polyacrylamide gel electrophoresis or high performance liquid chromatography.
- a nucleic acid or particular bacteria that are the predominant species present in a preparation is substantially purified.
- purified denotes that a nucleic acid or protein that gives rise to essentially one band in an electrophoretic gel.
- isolated nucleic acids or proteins have a level of purity expressed as a range.
- the lower end of the range of purity for the component is about 60%, about 70% or about 80% and the upper end of the range of purity is about 70%, about 80%, about 90% or more than about 90%.
- the term “gene” refers to a DNA sequence involved in producing a RNA or polypeptide or precursor thereof.
- the polypeptide or RNA is encoded by a full-length coding sequence (cds) or by intron-interrupted portions of the coding sequence, such as exon sequences.
- the gene involved is Parthenium argentatum allene oxide synthase (PaAos or Aos).
- PaAos cDNA and amino acid sequence is found in GenBank accession number X78166.2 which is cultivar G7-11 (wild-type/non-altered) (USDA publicly released guayule Germplasm line AZ-2 (Reg. No. GP-9; PI 599676)).
- the cDNA sequence is in SEQ ID NO: 9; the protein sequence is in SEQ ID NO: 10.
- SEQ ID NO: 12 is the cDNA sequence for PaAos and SEQ ID NO: 13 is the amino acid sequence for PaAos in guayule W6549 cultivar.
- SEQ ID NO: 14 is the cDNA sequence for PaAos and SEQ ID NO: 15 is the amino acid sequence for PaAos in guayule 478652 cultivar.
- a molecular marker uses SNPs within PaAos to differentiate the cultivars with differences in PaAos amino acid sequences which result in PaAos with different functionalities.
- nucleic acid refers to a polymer of ribonucleotides or deoxyribonucleotides. Typically, “nucleic acid” polymers occur in either single- or double-stranded form, but are also known to form structures comprising three or more strands.
- nucleic acid includes naturally occurring nucleic acid polymers as well as nucleic acids comprising known nucleotide analogs or modified backbone residues or linkages, which are synthetic, naturally occurring, and non-naturally occurring, which have similar binding properties as the reference nucleic acid, and which are metabolized in a manner similar to the reference nucleotides.
- Exemplary analogs include, without limitation, phosphorothioates, phosphoramidates, methyl phosphonates, chiral-methyl phosphonates, 2-O-methyl ribonucleotides, peptide-nucleic acids (PNAs).
- DNA “RNA”, “polynucleotides”, “polynucleotide sequence”, “oligonucleotide”, “nucleotide”, “nucleic acid”, “nucleic acid molecule”, “nucleic acid sequence”, “nucleic acid fragment”, and “isolated nucleic acid fragment” are used interchangeably herein.
- nucleic acids sizes are given in either kilobases (kb) or base pairs (bp), or nucleotides (nt).
- kb kilobases
- bp base pairs
- nt nucleotides
- Estimates are typically derived from agarose or acrylamide gel electrophoresis, from sequenced nucleic acids, or from published DNA sequences.
- proteins sizes are given in kiloDaltons (kDa) or amino acid residue numbers. Proteins sizes are estimated from gel electrophoresis, from sequenced proteins, from derived amino acid sequences, or from published protein sequences.
- nucleic acid sequence for each amino acid substitution also implicitly encompasses conservatively modified variants thereof (e.g., degenerate codon substitutions), the complementary (or complement) sequence, and the reverse complement sequence, as well as the sequence explicitly indicated.
- degenerate codon substitutions may be achieved by generating sequences in which the third position of one or more selected (or all) codons is substituted with mixed-base and/or deoxyinosine residues (see e.g., Batzer et al., Nucleic Acid Res. 19:5081 (1991); Ohtsuka et al., J. Biol. Chem.
- nucleic acid codons Because of the degeneracy of nucleic acid codons, one can use various different polynucleotides to encode identical polypeptides. Table 1, infra, contains information about which nucleic acid codons encode which amino acids and is useful for determining the possible nucleotide substitutions that are included in this invention.
- alterations in a polynucleotide that result in the production of a chemically equivalent amino acid at a given site, but do not affect the functional properties of the encoded polypeptide are well known in the art. “Conservative amino acid substitutions” are those substitutions that are predicted to interfere least with the properties of the reference polypeptide. In other words, conservative amino acid substitutions substantially conserve the structure and the function of the reference protein.
- a codon for the amino acid alanine, a hydrophobic amino acid may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine.
- a codon encoding another less hydrophobic residue such as glycine
- a more hydrophobic residue such as valine, leucine, or isoleucine.
- changes which result in substitution of one negatively charged residue for another such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine or histidine, is also expected to produce a functionally equivalent protein or polypeptide.
- Table 2 provides a list of exemplary conservative amino acid substitutions.
- Conservative amino acid substitutions generally maintain (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a beta sheet or alpha helical conformation, (b) the charge or hydrophobicity of the molecule at the site of the substitution, and/or (c) the bulk of the side chain.
- groups of amino acids that are conservative substitutions for each other are (i) alanine (Ala or A), serine (Ser or S), and threonine (Thr or T); (ii) aspartic acid (Asp or D) and glutamic acid (Glu or E); (iii) asparagine (Asn or N) and glutamine (Gln or Q); (iv) arginine (Arg or R) and lysine (Lys or K); (v) isoleucine (Ile or I), leucine (Leu or L), methionine (Met or M), and valine (Val or V); and (vi) phenylalanine (Phe or F), tyrosine (Tyr or Y), and tryptophan (Trp or W).
- amino acid(s) that are conservative substitutes for one amino acid are grouped by the following characteristics: aliphatic amino acids (alanine, glycine, isoleucine, leucine, and valine); hydroxyl or sulfur containing amino acids (cysteine, serine, methionine, and threonine); cyclic (proline); aromatic (phenylalanine, tryptophan, and tyrosine); basic (arginine, histidine, and lysine); acidic (aspartate and glutamate); and uncharged (asparagine and glutamine).
- wild-type guayule can be “high” rubber producers or “low” rubber producers.
- the invention also includes any conservative amino acids changes that can be made in these one, two, or more amino acids.
- primer refers to an oligonucleotide which may act as a point of initiation of DNA extension.
- a primer may occur naturally, as in a purified restriction digest, or may be produced synthetically.
- a primer is selected to be “substantially complementary” to a strand of specific sequence of the template.
- a primer must be sufficiently complementary to hybridize with a template strand for primer elongation to occur.
- a primer sequence need not reflect the exact sequence of the template.
- a non-complementary nucleotide fragment may be attached to the 5′ end of the primer, with the remainder of the primer sequence being substantially complementary to the strand.
- Non-complementary bases or longer sequences can be interspersed into the primer, provided that the primer sequence is sufficiently complementary with the sequence of the template to hybridize and thereby form a template primer complex for synthesis of the extension product of the primer.
- Oligonucleotides and polynucleotides that are not commercially available can be chemically synthesized e.g., according to the solid phase phosphoramidite triester method first described by Beaucage and Caruthers, Tetrahedron Letts. 22:1859-1862 (1981), or using an automated synthesizer, as described in Van Devanter et al., Nucleic Acids Res. 12:6159-6168 (1984). Other methods for synthesizing oligonucleotides and polynucleotides are known in the art. Purification of oligonucleotides is by either native acrylamide gel electrophoresis or by anion-exchange HPLC as described in Pearson & Reanier, J. Chrom. 255:137-149 (1983).
- nucleotides or amino acids refer to two or more sequences or sub-sequences that are the same or have a specified percentage of nucleotides or amino acids (respectively) that are the same (e.g., 80%, 85% identity, 90% identity, 99%, or 100% identity), when compared and aligned for maximum correspondence over a designated region as measured using a sequence comparison algorithm or by manual alignment and visual inspection.
- high percent identical in the context of two polynucleotides or polypeptides, refers to two or more sequences or sub-sequences that have at least about 80%, identity, at least about 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% nucleotide or amino acid identity, when compared and aligned for maximum correspondence, as measured using a sequence comparison algorithm or by visual inspection.
- a high percent identity exists over a region of the sequences that is at least about 16 nucleotides or amino acids in length.
- a high percent identity exists over a region of the sequences that is at least about 50 nucleotides or amino acids in length. In still another exemplary embodiment, a high percent identity exists over a region of the sequences that is at least about 100 nucleotides or amino acids or more in length. In one exemplary embodiment, the sequences are high percent identical over the entire length of the polynucleotide or polypeptide sequences.
- sequence comparison typically one sequence acts as a reference sequence, to which test sequences are compared.
- test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters may be used, or alternative parameters designated.
- sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters.
- Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison is conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol.
- the “complement” of a particular polynucleotide sequence is that nucleotide sequence which would be capable of forming a double-stranded DNA or RNA molecule with the represented nucleotide sequence, and which is derived from the represented nucleotide sequence by replacing the nucleotides by their complementary nucleotide according to Chargaff's rules (A ⁇ >T; G ⁇ >C) and reading in the 5′ to 3′ direction, i.e., in opposite direction of the represented nucleotide sequence (reverse complement).
- sense and antisense RNAs and dsRNA can be separately expressed in-vitro or in-vivo.
- In-vivo production of sense and antisense RNAs may use different chimeric polynucleotide constructs using the same or different promoters or using an expression vector containing two convergent promoters in opposite orientation.
- the sense and antisense RNAs which are formed e.g., in the same host cells or synthesized then combine to form dsRNA.
- dsRNA chimeric or fusion polynucleotide or a dsRNA molecule that such dsRNA formed (e.g., in plant cells) from sense and antisense RNA produced separately is also included. Also, synthetically made dsRNA and self-annealing RNA strands are included herein when the sense and antisense strands are present together.
- promoter refers to a polynucleotide that, in its native state, is located upstream or 5′ to a translational start codon of an open reading frame (or protein-coding region) and that is involved in recognition and binding of RNA polymerase and other proteins (trans-acting transcription factors) to initiate transcription.
- a “plant promoter” is a native or non-native promoter that is functional in plant cells, even if the promoter is present in a microorganism that infects plants or a microorganism that does not infect plants. The promoters that are predominately functional in a specific tissue or set of tissues are considered “tissue-specific promoters”.
- a plant promoter can be used as a 5′ regulatory element for modulating expression of a particularly desired polynucleotide (heterologous polynucleotide) operably linked thereto.
- a promoter When operably linked to a transcribable polynucleotide, a promoter typically causes the transcribable polynucleotide to be transcribed in a manner that is similar to that of which the promoter is normally associated.
- Plant promoters include promoters produced through the manipulation of known promoters to produce artificial, chimeric, or hybrid promoters. Such promoters can also combine cis-elements from one or more promoters, for example, by adding a heterologous regulatory element to an active promoter with its own partial or complete regulatory elements.
- the term “cis-element” refers to a cis-acting transcriptional regulatory element that confers an aspect of the overall control of gene expression.
- a cis-element may function to bind transcription factors, trans-acting protein factors that regulate transcription. Some cis-elements bind more than one transcription factor, and transcription factors may interact with different affinities with more than one cis-element.
- vector refers to DNA, RNA, a protein, or polypeptide that are to be introduced into a host cell or organism.
- the polynucleotides, protein, and polypeptide which are to be introduced into a host may be therapeutic or prophylactic in nature; may encode or be an antigen; may be regulatory in nature; etc.
- vectors including viruses, viroids, plasmids, bacteriophages, cosmids, and bacteria.
- An expression vector is nucleic acid capable of replicating in a selected host cell or organism.
- An expression vector can replicate as an autonomous structure, or alternatively integrate, in whole or in part, into the host cell chromosomes or the nucleic acids of an organelle, or it is used as a shuttle for delivering foreign DNA to cells, and thus replicate along with the host cell genome.
- an expression vector are polynucleotides capable of replicating in a selected host cell, organelle, or organism, e.g., a plasmid, virus, artificial chromosome, nucleic acid fragment, and for which certain genes on the expression vector (including genes of interest) are transcribed and translated into a polypeptide or protein within the cell, organelle or organism; or any suitable construct known in the art, which comprises an “expression cassette”.
- a “cassette” is a polynucleotide containing a section of an expression vector. The use of the cassettes assists in the assembly of the expression vectors.
- An expression vector is a replicon, such as plasmid, phage, virus, chimeric virus, or cosmid, and which contains the desired polynucleotide sequence operably linked to the expression control sequence(s).
- a heterologous polynucleotide sequence is operably linked to one or more transcription regulatory elements (e.g., promoter, terminator and, optionally, enhancer) such that the transcription regulatory elements control and regulate the transcription and/or translation of that heterologous polynucleotide sequence.
- a cassette has the heterologous polynucleotide operably linked to one or more transcription regulatory elements.
- operably linked refers to a first polynucleotide, such as a promoter, connected with a second transcribable polynucleotide, such as a gene of interest, where the polynucleotides are arranged such that the first polynucleotide affects the transcription of the second polynucleotide.
- the two polynucleotide molecules are part of a single contiguous polynucleotide.
- the two polynucleotides are adjacent.
- a promoter is operably linked to a gene of interest if the promoter regulates or mediates transcription of the gene of interest in a cell.
- a terminator is operably linked to the polynucleotide of interest if the terminator regulates or mediates transcription of the polynucleotide of interest, and in particular, the termination of transcription.
- Constructs of the present invention would typically contain a promoter operably linked to a transcribable polynucleotide operably linked to a terminator.
- recombinant when used with reference, e.g., to a cell, or nucleic acid, protein, or vector, indicates that the cell, organism, nucleic acid, protein or vector, has been altered by the introduction of a heterologous nucleic acid or protein or the alteration of a native nucleic acid or protein, or that the cell is derived from a cell so altered.
- recombinant cells may express genes/polynucleotides that are not found within the native (non-recombinant or non-altered or wild-type) form of the cell or express native genes in an otherwise abnormal amount—over-expressed, under-expressed or not expressed at all—compared to the non-altered cell or organism.
- transgenic is similar in meaning to “recombinant” “Transformation”, “transgenic”, and “transfection” refer to the transfer of a polynucleotide into a host organism or into a cell. Such a transfer of polynucleotides may result in genetically stable inheritance of the polynucleotides or in the polynucleotides remaining extra-chromosomally (not integrated into the chromosome of the cell). Genetically stable inheritance may potentially require the transgenic organism or cell to be subjected for a period of time to one or more conditions which require the transcription of some or all of the transferred polynucleotide in order for the transgenic organism or cell to live and/or grow.
- Polynucleotides that are transformed into a cell but are not integrated into the host's chromosome remain as an expression vector within the cell.
- Genetically altered organisms or cells containing the recombinant polynucleotide are referred to as “transgenic” or “transformed” organisms or cells or simply as “transformants”, as well as recombinant organisms or cells.
- a genetically altered organism is any organism with any changes to its genetic material involving the invention described herein, whether in the nucleus or cytoplasm (organelle).
- a genetically altered organism may be a recombinant or transformed organism.
- a genetically altered organism may also be an organism that was subjected to one or more mutagens or the progeny of an organism that was subjected to one or more mutagens and has mutations in its DNA caused by the one or more mutagens, as compared to the wild-type organism (i.e., organism not subjected to the mutagens) or the non-altered organism (i.e., one that contains alterations that are not the subject matter of this invention).
- an organism that has been bred to incorporate a mutation into its genetic material is a genetically altered organism.
- a non-altered guayule contains none of the described genetic changes nor has been treated with any of the described external substance, but may contain pre-existing changes which are not part of this invention.
- An altered guayule (which also is a genetically altered guayule) may contain DNA mutations which change PaAos' amino acid sequence, even if that sequence exists in a non-altered plant. Such DNA mutations may be induced by a mutagen (EMS, UV light, other radiation, etc.).
- Transformation and generation of genetically altered monocotyledonous and dicotyledonous plant cells is well known in the art. See, e.g., Weising, et al., Ann. Rev. Genet. 22:421-477 (1988); U.S. Pat. No. 5,679,558 ; Agrobacterium Protocols , ed: Gartland, Humana Press Inc. (1995); and Wang, et al. Acta Hort. 461:401-408 (1998).
- a method to generate genetically altered guayule is described in U.S. Pat. No. 9,018,449 (Dong & Cornish) and in Dong, et al., Plant Cell Reports 25:26-34 (2006).
- a method to generate transplastomic guayule is provided in U.S. Patent Application Publication 2014/0325699, contents of which are expressly incorporated herein.
- the choice of method varies with the type of plant to be transformed, the particular application and/or the desired result.
- the appropriate transformation technique is readily chosen by the skilled practitioner.
- a polynucleotide encoding PaAos (SEQ ID NOs: 9, 12, and/or 14), the reverse complement of PaAos, or a portion thereof (e.g., SEQ ID NO: 11), operably linked to one or two appropriate promoters, can be stably inserted in a conventional manner into the genome (cytoplasmic genome or nucleic genome) of a single plant cell, and the altered plant cell can be used in a conventional manner to produce a genetically altered plant that produces the dsRNA of this invention.
- a disarmed Ti-plasmid, containing the polynucleotide of this invention, in Agrobacterium tumefaciens can be used to genetically alter the plant cell, and thereafter, a genetically altered plant can be regenerated from the genetically altered plant cell using the procedures described in the art, for example, in EP 0 116 718, EP 0 270 822, WO 84/02913 and EP 0 242 246. Plant regeneration from cultured protoplasts is described in Evans et al., Protoplasts Isolation and Culture , in Handbook of Plant Cell Culture , pp.
- Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee, et al., Ann. Rev. of Plant Phys. 38:467-486 (1987).
- Preferred Ti-plasmid vectors each contain the polynucleotides described herein between the border sequences, or at least located to the left of the right border sequence, of the T-DNA of the Ti-plasmid.
- other types of vectors may be used to transform the plant cell, using procedures such as direct gene transfer (as described, for example in EP 0 233 247), pollen mediated transformation (as described, for example in EP 0 270 356, WO 85/01856, and U.S. Pat. No. 4,684,611), plant RNA virus-mediated transformation (as described, for example in EP 0 067 553 and U.S. Pat. No. 4,407,956), liposome-mediated transformation (as described, for example in U.S.
- the resulting genetically altered plant can be used in a conventional plant breeding scheme to produce more genetically altered plants with the same characteristics or to introduce the polynucleotide into other varieties of the same or related plant species.
- Seeds, which are obtained from the genetically altered plants contain the expression vector as a stable genomic insert.
- Altered plants include plants having or derived from root stocks of plants containing the expression vector. Hence, any non-altered grafted plant parts inserted on a genetically altered plant or plant part are included in the invention.
- an expression vector or cassette (made from DNA) that encodes, at a minimum, a first promoter and the dsRNA sequence of interest such that the promoter sequence is 5′ (upstream) to and operably linked to the dsRNA sequence.
- the expression vector or cassette may optionally contain a second promoter (same as or different from the first promoter) upstream and operably linked to the reverse complementary sequence of the dsRNA sequence such that two strands of RNA that are complementary to each other are produced.
- the expression vector or cassette can contain one promoter operably linked to both the dsRNA sequence (sense strand) in question and the complement or reverse complement of the dsRNA sequence (anti-sense strand) in question, such that the transcribed RNA bends on itself and the two desires sequences anneal.
- a second expression vector or cassette (made from DNA) may encode, at a minimum, a second promoter (same as or different from the promoter) operably linked to the reverse complementary sequence of the dsRNA such that two strands of complementary RNA are produced in the plant.
- the expression vector(s) or cassette(s) is/are inserted in a plant cell genome (nuclear or cytoplasmic).
- the promoter(s) used should be a promoter(s) that is/are active in a plant and is/are heterologous to PaAos (not normally driving the transcription of RNA of genomic PaAos).
- the expression vector or cassette may have other transcription regulatory elements, such as enhancers, terminators, etc.
- Promoters that are active in plants are well-known in the field. Such promoters may be constitutive, inducible, and/or tissue-specific.
- constitutive plant promoters include 35S promoters of the cauliflower mosaic virus (CaMV) (e.g., of isolates CM 1841 (Gardner, et al., Nucleic Acids Research 9:2871-2887 (1981)), CabbB-S (Franck, et al., Cell 21:285-294 (1980)) and CabbB-JI (Hull and Howell, Virology 86:482-493 (1987))), ubiquitin promoter (e.g., the maize ubiquitin promoter of Christensen, et al., Plant Mol.
- CaMV cauliflower mosaic virus
- CM 1841 Gibdner, et al., Nucleic Acids Research 9:2871-2887 (1981)
- CabbB-S Fack, et al., Cell 21:285-294 (1980)
- Tissue-specific promoters are promoters that direct a greater level of transcriptional expression in some cells or tissues of the plant than in other cells or tissue.
- tissue-specific promoters include the phosphoenolpyruvate carboxylase (PEP or PPC1) promoter (Pathirana, et al., Plant J. 12:293-304 (1997), and Kausch, et al., Plant Mol. Biol. 45(1):1-15 (2001)), chlorophyll A/B binding protein (CAB) promoter (Bansal, et al., Proc. Natl. Acad. Sci. USA 89(8):3654-8 (1992)), small subunit of ribulose-1,5-bisphosphate carboxylase (ssRBCS) promoter (Bansal, et al., Proc. Natl. Acad. Sci.
- PEP or PPC1 phosphoenolpyruvate carboxylase
- CAB chlorophyll A/B binding protein
- ssRBCS small subunit of ribulose-1,5-bisphosphate carboxylase
- senescence activated promoter SEE1 (Robson, et al., Plant Biotechnol. J. 2(2):101-12 (2004)), and sorghum leaf primoridia specific promoter (RS2) (GenBank Accession No. E1979305.1).
- SEE1 senescence activated promoter
- RS2 sorghum leaf primoridia specific promoter
- phloem specific promoters are the sucrose synthase-1 promoters (CsSUS1p and CsSUS1p-2) (Singer et al., Planta 234:623-637 (2011)) and the phloem protein-2 promoter (CsPP2) (Miyata et al., Plant Cell Report 31(11):2005-2013 (2012)) from Citrus sinensis .
- a plant-expressible promoter may also be a wound-inducible promoter, such as the promoter of the pea cell wall invertase gene (Zhang, et al., Plant Physiol. 112:1111-1117 (1996)).
- RNA polymerase promoters that may be used are promoters from microorganisms, such as, but not limited to the bacteriophage T7 RNA polymerase promoter, yeast Galactose (GAL1) promoter, yeast glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter, yeast Alcohol Oxidase (AOX) promoter.
- GAL1 yeast Galactose
- GAP yeast glyceraldehyde-3-phosphate dehydrogenase
- AOX yeast Alcohol Oxidase
- elements used to increase transcription expression in plant cells include, but are not limited to, an intron (e.g., hsp70 intron) at the 5′ end or 3′ end of the chimeric gene, or in the coding sequence of the chimeric dsRNA gene (such as, between the region encoding the sense and antisense portion of the dsRNA), promoter enhancer elements, duplicated or triplicated promoter regions, 5′ leader sequences different from the chimeric gene or different from an endogenous (plant host) gene leader sequence, 3′ untranslated sequences different from the chimeric gene or different from an endogenous (plant host) 3′ untranslated sequence.
- an intron e.g., hsp70 intron
- promoter enhancer elements e.g., duplicated or triplicated promoter regions
- 5′ leader sequences different from the chimeric gene or different from an endogenous (plant host) gene leader sequence e.g., hsp70 intron
- promoter enhancer elements
- the expression vector or cassette could contain suitable 3′ untranslated transcription regulation sequences (i.e., transcript formation and polyadenylation sequences).
- suitable 3′ untranslated transcription regulation sequences i.e., transcript formation and polyadenylation sequences.
- Potential polyadenylation and transcript formation sequences include those sequences in the nopaline synthase gene (Depicker, et al., J. Molec. Appl. Genetics 1:561-573 (1982)), the octopine synthase gene (Gielen, et al., EMBO J.
- plant includes whole plants, plant organs, progeny of whole plants or plant organs, embryos, somatic embryos, embryo-like structures, protocorms, protocorm-like bodies (PLBs), and suspensions of plant cells.
- Plant organs comprise, e.g., shoot vegetative organs/structures (e.g., leaves, stems and tubers), roots, flowers and floral organs/structures (e.g., bracts, sepals, petals, stamens, carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat) and fruit (the mature ovary), plant tissue (e.g., vascular tissue, ground tissue, and the like) and cells (e.g., guard cells, egg cells, trichomes and the like).
- the class of plants that can be used in the method of the invention is generally as broad as the class of higher and lower plants amenable to the molecular biology and plant breeding techniques described herein, specifically angiosperms (monocotyledonous (monocots) and dicotyledonous (dicots) plants). It includes plants of a variety of ploidy levels, including aneuploid, polyploid, diploid, haploid and hemizygous.
- the genetically altered plants described herein are guayule plants.
- Rubber yield may be expressed as a product of rubber content (% rubber) and biomass (dry weight/unit area). Thus, rubber yield may be improved by increasing either biomass and/or rubber content.
- the altered guayule described herein produce more rubber and have higher rubber content than non-altered guayule, thereby increasing the processing efficiency of the guayule shrub.
- Various methods exist to create a mutation are well-known to one of ordinary skill in the art.
- One method is by transforming the plant with a plasmid containing 5′ sequence and 3′ sequence of the gene and allowing a cross-over event to occur, thereby excising the DNA from the plant's genome that is between the plasmid's 5′ sequence and 3′ sequence.
- transposon-mediated mutation to delete or add DNA to PaAos which would result in the encoded protein having a reduced functionality compared to a non-altered PaAos.
- Two other methods involve using a chemical mutagen (such as ethyl methanesulfonate (EMS)) or physical agents (radiation, UV, or proton, for example) to generate genetic mutations in plant cells and/or germplasm.
- EMS ethyl methanesulfonate
- physical agents radiation, UV, or proton, for example
- TALEN ethyl methanesulfonate
- CaAos9 CRISPR-Cas9
- targeted cleavage events to induce targeted mutagenesis, induce targeted deletions of cellular DNA sequences, and facilitate targeted recombination and integration at predetermined chromosomal locations to generate one or more of the null mutations discussed above or to reduce the mutated protein's functionality.
- Cleavage occurs by using specific nucleases such as engineered zinc finger nucleases (ZFN), transcription-activator like effector nucleases (TALENs), or using the CRISPR/Cas9 system with an engineered crRNA/tracr RNA (‘single guide RNA’) to guide specific cleavage.
- ZFN engineered zinc finger nucleases
- TALENs transcription-activator like effector nucleases
- CRISPR/Cas9 system with an engineered crRNA/tracr RNA engineered crRNA/tracr RNA
- U.S. Patent Publication 2008/0182332 describes the use of non-canonical zinc finger nucleases (ZFNs) for targeted modification of plant genomes
- U.S. Patent Publication 2009/0205083 describes ZFN-mediated targeted modification of a plant EPSPS locus
- U.S. Patent Publication 2010/0199389 describes targeted modification of a plant Zp15 locus
- CRISPR/Cas9 Information on CRISPR/Cas9 system is found, e.g., at en.wikipedia.org/wiki/CRISPR; neb.com/tools-and-resources/feature-articles/crispr-cas9-and-targeted-genome-editing-a-new-era-in-molecular-biology; and Cong, et al., Science, 339:819-823 (2013).
- Sigma-Aldrich Sigma-Aldrich (St. Louis, Mo.) and Origene Technologies, Inc. (Rockville, Md.) are among the companies that sell CRISPR/Cas9 kits.
- Another embodiment of this invention is the generation of altered guayule having a genetic alteration in PaAos such that the altered guayule produces more rubber than produced by non-altered guayule.
- the altered guayule may contain one of more of the following alterations: (1) DNA encoding (i) anti-sense RNA for PaAos, (ii) double-stranded RNA for PaAos, (iii) a mutation within PaAos that encodes a PaAos with reduced or no function; and/or (2) exogenously administered PaAos dsRNA.
- the combination of any of the above alterations and exposure to cold temperatures result in production of increased amounts of rubber than produced by the non-altered plant exposed to the same temperatures for the same time period.
- bacterium includes both a single bacterium and a plurality of bacteria.
- nucleic acid consisting essentially of means a polynucleotide that differs from a reference nucleic acid sequence by 20 or fewer nucleotides and also perform the function of the reference polynucleotide sequence. Such variants include sequences which are shorter or longer than the reference nucleic acid sequence, have different residues at particular positions, or a combination thereof.
- PaAos genetically altered P. argentatum plants are generated in which either PaAos is over-expressed or PaAos is silenced by RNAi.
- the various plasmids used to achieve the overexpression or silencing of PaAos in guayule are shown in FIG. 1 .
- the guayule Aos (PaAos) is amplified by PCR using genomic DNA as a template.
- the primers used to amplify PaAos are designed from the cDNA PaAos sequence published in NCBI database (GeneBank accession no.
- X78166.2 forward primer 5′-cttaagaggtggtATGGACCCATCGTCTAAACCC-3′ (SEQ ID NO: 1) and reverse primer 5′-ggatccTCATATACTAGCTCTCTTCAGGG-3′ (SEQ ID NO: 2).
- the nucleotides in lower case and underlined in the forward primer are the recognition nucleotides for restriction enzyme AflII; the nucleotides in lower case and underlined in the reverse primer are the recognition nucleotides for restriction enzyme BamHI.
- the PCR cycle program is the following: 94° C. for 2 minutes (initial heating step) and PaAos is amplified at 40 cycles of 94° C.
- the resulting amplicon is purified and subcloned into pGEM T Easy vector (Promega, Madison, Wis.) using manufacturer's recommended protocol and sequenced to confirm the sequence of the plasmids.
- the cDNA sequence is in SEQ ID NO: 9 and the amino acid sequence is in SEQ ID NO: 10. Subsequently, the PaAos amplicon is cut using AflII and BamHI.
- Plasmid pND6 has a Nos promoter driving the NPTII gene for conferring kanamycin resistance and a potato ubiquitin promoter (Garbarino and Belknap, Plant Mol. Biol. 24:119-127 (1994)) controlling the GUSplus gene (CambiaLabs, Canberra, Australia). See FIG. 1 .
- Plasmid pND6-Aos ( FIG. 1 ) is generated by replacing the GUSplus gene in pND6 with cDNA PaAos sequence (SEQ ID NO: 9). Plasmid pND6-AosiL ( FIG.
- plasmids pND6, pND6-AosiL, and pND6-Aos are used to transform Agrobacterium EHA101 competent cells using the protocol described in Hood, et al., J. Bacteriol. 168:1291-1301 (1986).
- the transformed Agrobacterium EHA101 either harboring pND6, pND6-AosiL, or pND6-Aos are used to transform guayule G7-11 using the protocols set forth below. See also Dong, et al. (2006) and Dong, et al., Industrial Crops and Products 46:15-24 (2013).
- the overnight Agrobacterium culture are prepared by inoculating 50 ⁇ L glycerol stock into a 50 mL Falcon tube containing 5 mL LB medium plus 40 mg/L rifampcin and 200 mg/L spectinomycin, and shaking at 200 rpm at 28° C. The suspension then is centrifuged for 15 minutes at 1600 ⁇ g at room temperature.
- MSB1TK30 MS medium containing BA (1 mg/L), sucrose (30 g/L), phytagel (3 g/L), timentin (250 mg/L), and kanamycin (30 mg/L)) for selection under low light for two weeks.
- the leaf strips are then subcultured every 2 weeks under high light till green shoots emerged.
- Green shoots 10 mm and longer are transferred to 1 ⁇ 2MS10.1TK10 for rooting (same as 1 ⁇ 2MSI0 but with timentin (250 mg/L) and kanamycin (10 mg/L)). After 2-4 weeks, the rooted plantlets are micropropogated and subsequently transplanted into soil.
- pND6-Aos PaAos in forward orientation; SEQ ID NO: 9
- pND6-AosiL PaAos in the reverse orientation (a portion of reverse complement of PaAos is SEQ ID NO: 11)
- pND6 negative control
- DNA is extracted from genetically altered plants using Sigma Kit (Sigma-Aldrich, St. Louis, Mo.).
- Approximately 150 mg leaf tissue (3 leaf tissues) are cut from the plants grown in tissue-cultured, placed into 2 mL tubes and snapped-frozen in liquid nitrogen. A bead is added to pulverize the tissue into a fine powder at a frequency of 30/s for 1 minute using the mixer mill MM 400 tissue lyser (Verder Scientific, Inc., Newtown, Pa.).
- PCR is carried out in 50 ⁇ L mixture containing Taq 2 ⁇ Master Mix (New England Biolabs, Ipswich, Mass.), 200 ng guayule genomic DNA or 20 pg plasmid DNA, and 100 ng of PaAos specific primers; namely SEQ ID NOs: 1 and 2 for guayule transformed with pND6-Aos; and SEQ ID NOs: 3 and 4 for guayule transformed with pND6-AosiL. See FIG. 2 . After heating the samples to 94° C. for 2 minutes, the reaction proceeds with 35 cycles of 94° C. for 30 seconds, 71° C.
- PCR products are separated by electrophoresis on a 1% (w/v) agarose gel.
- the band for the overexpression lines is at ⁇ 1.4 kbp, as expected; the band for the RNAi lines is at ⁇ 0.5 kbp as expected.
- RNA levels are further screened to determine the RNA level (see Table 3). Leaves from the various genetically modified plants (which are grown in tissue culture) are collected and snap-frozen in liquid nitrogen for RNA extraction. RNA is extracted using TRIzol® according to manufacturer's recommended protocol (Ambion, Pittsburgh, Pa.). RNA concentration is quantified with the NanoDrop ND1000 (ThermoScientific, Wilminton, Del.).
- RNA cleanup is performed using the RNeasy MinElute Cleanup kit according to manufacturer's recommended protocol (Qiagen Inc., Valencia, Calif.). The RNA is eluted with 30-50 ⁇ L of RNase-free water along with on-column DNase1 treatment.
- cDNA is generated using iScript cDNA synthesis kit (Bio-Rad, Hercules, Calif.) according to the manufacturer's recommended protocol for semi-quantitative PCR and real-time quantitative PCR (qRT-PCR). An amount of 1 ⁇ g of RNA is used in the 20 mL reaction mixture. For qRT-PCR, 2 ⁇ L of the diluted cDNA (1:20) is used in a 15 ⁇ L reaction mixture. In the qRT-PCR volume, 7.5 mL of iQ SYBR® Green Supermix is used (Bio-Rad, Hercules, Calif.).
- the qRT-PCR is run using the 7500 Fast Real-Time PCR system (Applied Biosystem, Waltham, Mass.) with the following thermal cycle: 95° C. pre-incubation for 3 minutes; amplification is performed for 40 cycles at 95° C. for 15 seconds and at 60° C. for 30 seconds; the dissociation stage is set for 95° C. for 15 seconds, at 60° C. for 1 minute, and at 95° C. for 15 seconds.
- Each qRT-PCR run is performed with three independent tissue samples, each sample having two technical replicates.
- the 18S gene ( ⁇ 200 bp) is used as an internal control.
- the primers used for each sequence, PCR reaction conditions, and the expected amplicon size are contained in FIG. 2 .
- Crossing point value which is the point at which the fluorescence crosses the threshold
- melting curve analyses are noted.
- the melting curve data are collected for all genes to ensure a single peak, indicating amplification of a specific region by a pair of primers.
- the relative expression values are calculated using the 2(-Delta C(T)) method (Livak and Schmittgen, Methods, 25:402-408 (2001)). See Table 3 below.
- RNA is extracted from leaves, petiole, stem, root, young flower, mature flower, peduncle, stembark of 8-week-old tissue-cultured genetically altered plants as well as 2-month-old greenhouse grown genetically altered plants using the protocol described above.
- qRT-PCR is performed as described above on these samples of total RNA.
- Primers (SEQ ID NOs: 7 and 8 in FIG. 2 ) are designed to amplify ⁇ 200 bp PCR product in PaAos coding sequence. The expression level for each tissue are compared to the tissue cultured and greenhouse leaf tissues, respectively.
- the 18S gene ( ⁇ 200 bp) (forward primer is SEQ ID NO: 5 and reverse primer is SEQ ID NO: 6, described supra and in FIG. 2 ) is used as an internal control. As shown in Table 4, infra, the largest level of PaAos expression is present in the stem, root and stembark tissues, suggesting that these tissues are sites in which PaAos is functioning.
- Rooted plantlets (genetically altered, empty vector transformed (pND6 without PaAos), and wild-type control) from transferred shoot tips are grown on half-strength MS medium (PhytoTechnology Laboratories, Overland Park, Kans.) in Magenta boxes (Caisson Labs, Smithfield, Utah) for 6 weeks. The top part of the plantlets are separated from the medium and lyophilized for 48 hours. The dried tissues are placed in a 50 mL stainless steel grinding jar containing grinding ball, frozen in liquid nitrogen for 5 minutes and finely ground using the Retsch mixer mill MM 400 at a frequency of 30/second for 1 minute (Verder Scientific Inc., Newtown, Pa.).
- the pND6-AosiL plants have 1.5 to 2 times more rubber than G7-11, pND6 and pND6-Aos in tissue-cultured environment (Table 5).
- Table 5 the rubber content is quantified from leaf and stems of the indicated guayule genotypes grown in MS media.
- the genetically altered guayule plants are transplanted into soil and grown for 2 months under 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h) in growth chamber conditions, representing a microcosm of what guayule plants experience in the field during winter.
- pND6-AosiL plants also exhibited elevated rubber content, having up to 31% times more rubber in comparison with G7-11, pND6 and pND6-Aos plants (Table 6).
- Table 6 the rubber content is quantified from shoots and roots of the indicated guayule genotypes grown in soil. These plants are approximately 4 months old when rubber content is analyzed (tissue culture (approx. 1.5 months), greenhouse (approx. 1 month), and growth chamber (approx. 2 months)).
- Plants are transferred to soil from tissue culture and are grown in a growth chamber environment. Error bars represent three biological plants with three technical replicates each. *, ** and *** indicate significant difference in comparison to G7-11 and/or pND6 (controls) at p > 0.05, 0.005 and 0.0005, respectively.
- cold treatment alone increased shoot rubber content in the control (pND6-12) by 19%—from an average of 1.04% to 1.24%.
- cold treatment of the Aos-downregulated plants (pND6-AosiL) increased rubber by 27%—from average 1.50% to 1.90%.
- cold treatment increased the rubber content for the control (pND6-12) by 5.1% (from 0.79 to 0.83% rubber), but cold treatment of the Aos-downregulated plants (pND6-AosiL) increased rubber by 57%—from average 0.82% to 1.28%.
- Table 7, infra From the ASE results, the increased in rubber content is very apparent in the pND6-AosiL genotypes.
- WRPs Guayule washed rubber particles
- pND6-AosiL and pND6-Aos are isolated from genetically altered guayule lines (pND6-AosiL and pND6-Aos) and non-altered guayule using the protocol set forth in Cornish and Backhaus, Phytochemistry, 29: 3809-3813 (1990). Rubber particles are extracted from non-altered and genetically altered 1 year old greenhouse plants. First, ⁇ 60 g to ⁇ 70 g of stembark tissues are peeled off from the plant, grounded with a blender containing cold-extraction buffer, and further purified with cold-washed buffer three times by centrifugation. The protein extracts (1 mg) are run on an SDS-PAGE and detected with silver staining.
- endogenous Aos protein runs as ⁇ 53 kDa in the non-altered and overexpressed plants but not in the RNAi lines.
- 50 ⁇ L of the protein extracts are aliquoted 3 ⁇ on a weighing paper, oven-dried over-night in a 60° C. incubator and weighed the next day. Generally, approximately 0.5 mg/ ⁇ L to approximately 1.5 mg/ ⁇ L WRPs are extracted.
- PaAos is an enzyme in the biosynthetic pathway that produces several different plant hormones, including jasmonic acid, SA, abscisic acid, gibberellin A 20 , gibberellin A 1 , and gibberellin A 3 .
- the amount of these hormones is quantified in genetically altered (pND6-AosiL and pND6-Aos), empty vector transformed (pND6 without PaAos; control), and wild-type (G7-11, control) tissue-cultured guayule plants using the protocol described in Pan et al., Nature Protocols 5:986-992 (2010). See Table 8, infra. Briefly, leaves and stems are snap-frozen and ground to powder with mortar and pestle.
- Solvent extraction solution containing 2-propanol/H 2 O/concentrated HCl (2:1:0.002; vol/vol/vol) and internal standards are added to ⁇ 50 mg of pre-weighed tissues. After solvent extraction, sample concentration and re-dissolution, 50 ⁇ L of the sample solution is placed into the liquid chromatography-tandem spectrometry (Agilent GC-MS 5977A; Agilent Technologies, Santa Clara, Calif.) for hormone analysis. Three biological plants, with three technical replicates of each plant, are used.
- pND6-Aos Three independent events from each of the overexpression (pND6-Aos) and of the silenced (pND6-AosiL) lines; as well as two pND6 and one wild-type (G7-11) controls are selected for further studies.
- pND6-AosiL plants grown in greenhouse (data not shown) and growth chamber conditions are bigger (see FIG. 3 ), have darker green leaves (data not shown), and increased chlorophyll measurement than the wild type and other genetically altered plants (see FIG. 4 ).
- FIG. 3 Under 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h) environments, pND6-AosiL plants are significantly taller and wider in both conditions.
- pND6-AosiL genotypes have also a greater number of stems than the wild-type and empty vector controls.
- Well-branched guayule plants are an indicator of having increased rubber yield because of the presence of more sink tissue available to store rubber.
- the mature stembark tissues in pND6-AosiL have thicker diameter (ranging from approximately 35% to approximately 54%) under both 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h) in comparison to the controls and pND6-Aos. See FIG. 5 .
- the photosynthetic rate of the plants is measured using LI-COR 6400xt (LI-COR Biosciences, Lincoln, Nebr.) to measure the photosynthetic rate. Measurements are taken between 0900 to 1200 h. Fully expanded middle leaf are clamped on the Li-Cor head. After the measured and set parameters are stabilized, the reading is taken. The middle leaf position is chosen because this position shows significant differences based on chlorophyll meter measurements, FIG. 4 . (SPAD-502; Minolta Camera Ltd., Japan). The pND6-AosiL plants exhibit higher photosynthetic rate (23-31%) in comparison to G7-11, pND6 and pND6-Aos plants (Table 9, infra).
- the length of the polymer chain is the primary determinant of quality in natural rubber.
- Gel permeation chromatography is used to measure the molecular weight of rubber from guayule tissue culture plants' extracts. Cyclohexane extractables collected from ASE (see Example 3 and Table 5 supra) are re-suspended in approximately 3 mL of tetrahydrofuran (THF) overnight with gentle shaking (Multi-Purpose Rotator. Thermo Scientific, Waltham. Mass.).
- the solution is syringe-filtered through a 1.6 ⁇ m glass microfiber GF/A filter (Whatman GE Healthcare, Piscataway, N.J.), then injected into a Hewlett Packard 1100 series HPLC (1.0 mL/min flow rate, 50 ⁇ L injection volume, THF continuous phase) and size exclusion separated by two Agilent PL gel 10 ⁇ m Mixed-B columns in series (35° C.) (Santa Clara, Calif.). The resulting chromatograms are used to calculate the rubber molecular weight shown in FIG. 6 (using Astra software (Wyatt Technology Corp., Santa Barbara, Calif.)).
- the molecular weight of natural rubber from three pND6-AosiL transformed guayule plants is greater than from wild-type guayule line G7-11, two negative control pND6 transformed guayule plants and three pND6-Aos transformed guayule plants (overexpressed) indicating better quality rubber in the PaAos silenced guayule plants.
- the asterisks (*) and (**) above the three pND6-AosiL transformed guayule plant lines indicate significant difference in comparison to the negative control pND6 transformed guayule plant lines at p>0.05 and p>0.005, respectively.
- guayule cultivars grown in tissue culture are evaluated for their rubber content and expression of PaAos gene.
- the combination of ASE method (see Example 3 supra) and qRT-PCR (see the protocols and primers discussed in Example 2, supra, and FIG. 2 ) are used to compare rubber content to the level of PaAos gene expression.
- seeds from guayule lines (PI 478648, W6 549, PI 478651, PI 478652, PI 478653, PI 478654, PI 478655, and PI 478662) are obtained from a public germplasm bank (USDA-ARS National Plant Germplasm System, Parlier, Calif.). The seeds are germinated and plants grown in tissue culture medium for 8 weeks.
- the natural rubber content is determined by standard methods, as described previously (ASE). The rubber content varied significantly between lines, from 0.95% to 1.73% (Table 10). Cultivar (line) W6 549 has the lowest average rubber content (%) and cultivar PI 478652 has the largest average rubber content (%) (see Table 10).
- PaAos gene expression for cultivars W6 549 and PI 478652 are determined by standard methods (qRT-PCR, see Example 2, supra).
- Shoot tissues (leaf and stem) are collected into 2 mL tubes and are snap-frozen in liquid nitrogen and then hand pulverized (mortar and pestle).
- RNA is extracted using the TRIzol® method (Ambion, Pittsburgh, Pa.) using manufacturer's recommended protocol.
- the RNA concentration is quantified with the NanoDrop ND1000 (ThermoScientific, Wilmington, Del.).
- An RNA cleanup is performed using RNeasy MinElute Cleanup kit using manufacturer's recommended protocol (Qiagen Inc., Valencia, Calif.).
- the RNA is eluted with 30-50 tit of RNase-free water along with on-column DNase1 treatment.
- RNA Ribonucleic acid
- cDNA complementary DNA
- PaAos coding sequence in the two lines, W6 549 cultivar (low rubber producer) and PI 478652 cultivar (high rubber producer) are determined by PCR, and the sequences are compared to G7-11 cultivar sequence.
- Extraction of the cDNA from the agarose gel is performed with QIAquick Gel Extraction kit (Qiagen, Germantown, Md.) using manufacturer's recommended protocol.
- the 1.4 kb band visualized with ethidium bromide is excised from the gel with a clean razor blade.
- 300 ⁇ l of Buffer QG pH 7.5 is added for every 100 mg of gel slice with the DNA fragment size of 100 bp-4 kb.
- the supernatant is collected as the purified cDNA product.
- three independent PCR products are sent to Elim Biopharmaceuticals (Hayward, Calif.) for analysis.
- the sequence alignment is performed using softwares MEGA 6.06 (Tamura, et al., Mol. Bio. and Evol., 30:2725-2729 (2013)) and T-Coffee (Notredame, et al., J. Mol. Biol., 302:205-217 (2000)).
- MEGA 6.06 Trimura, et al., Mol. Bio. and Evol., 30:2725-2729 (2013)
- T-Coffee Notredame, et al., J. Mol. Biol., 302:205-217 (2000).
- FIGS. 8A-8C a few SNPs exist which give rise to changes in the amino acid sequences (see FIG. 9 ).
- amino acids at positions 318, 408 and 459 are D, I and L in W6 549 (“W6549”) cultivar while PI 478652 (“478652”) cultivar has N, V and W, respectively ( FIG. 9 ). These differences in three amino acids result in different PaAos functionality which result in different amounts of rubber being produced.
- PaAos' functionality By reducing PaAos' functionality, one increases rubber production in guayule. As discussed previously, reducing the amount of PaAos by silencing PaAos expression or translation increases rubber production. Null mutations (such as, but not limited to, insertions that disrupt translation of a functional protein, changing slice site recognition nucleotide(s), and changing ATG initiation codon) alter the production of functional PaAos which result in an increase in rubber production. Alternations in PaAos' DNA sequence that result in specific amino acid changes within PaAos also increase rubber production.
- DNA alterations that change PaAos sequence from D318, I408 and/or L459 (present in W6 549 cultivar, low rubber producer) to N318, V408 and W459 (present in PI 478652 cultivar, high rubber producer) (or any other non-conservative amino acid for D318, I408, and/or L459) result in an increase in rubber production because of a decrease in PaAos functionality.
- altering PaAos' DNA sequence encoding S332, E336, R339, S359, and/or S411 to a sequence encoding non-conservative amino acids results in reducing PaAos' functionality and thus increasing rubber production. See, Pan, et al., J. of Bio. Chem., 273(29):18139-18145 (1998), contents of which are expressly incorporated by reference.
- guayule To screen guayule, one obtains a tissue sample from the guayule to be screened, isolates the sample's mRNA or total RNA, and conduct a PCR assay (regular PCR or RT-PCR or qRT-PCR) using PaAos primers that surround the nucleotides encoding amino acids N318, V408 and W459 to identify guayule plants encoding these amino acids which indicate that the guayule produces more rubber than a guayule not having these amino acids within PaAos. Guayule seedlings (plants that are between 2-4 weeks and 8-10 weeks post-germination) are screened.
- a PCR assay regular PCR or RT-PCR or qRT-PCR
- guayule plants that are approximately 2 or 3 months old can be screened. While any plant tissue can be used to conduct the SNP analysis, bark and leaves may be easier to sample than other tissue (such as roots).
- 5′-CCTACTCGACGCCAAGAG-3′ forward, SEQ ID NO: 18
- 5′-TTCAGCTGAGCATGTCTAGGT-3′ reverse, SEQ ID NO: 19
- 5′-GGCATTGTTGAAGTACATATGG-3′ forward, SEQ ID NO: 20
- 5′-CCAAAGGAGACTCGCCTAATT-3′ SEQ ID NO: 21
- guayule containing PaAos with S332, E336, R339, S359, and/or S411, in combination with one or more of D318, I408 and L459 are also low rubber producing plants. Primers are designed to cover the SNPs for these amino acids which are used to identify low rubber producing guayule.
- guayule containing PaAos with non-conservative amino acids to D318, S332, E336, R339, S359, I408, S411, or L459, or a combination thereof are high rubber producing plants, and primers are designed to cover the SNPs for these amino acids which are used to identify high rubber producing plants.
- Other techniques are known to one of ordinary skill in the art for identifying amplicons with the indicated SNPs.
- an ELISA or other type of antibody assay can distinguish between PaAos containing N318, V408 and/or W459 (PI 478652 cultivar (high producer)) and PaAos containing D318, I408 and/or L459 (W6 549 cultivar (low producer)), with or without one or more of S332, E336, R339, S359, and S411.
- An ELISA using a monoclonal antibody (mAb) that is specific for PaAos containing N318, V408 and/or W459, with or without one or more non-conservative amino acids substituted for S332, E336, R339, S359, and S411, would identify high rubber producing plants.
- an ELISA using a mAb that is specific for PaAos containing D318, I408 and/or L459 with or without one or more amino acids S332, E336, R339, S359, and S411, would identify low rubber producing plants.
- Protein isolated from tissue sample, as described above, can be contacted with the mAb(s) in the ELISA which then changes color to indicate the presence of PaAos having the particular amino acids and structure to which the mAb binds.
- Guayule encoding PaAos with conservative amino acid substitutions for N318, V408 and/or W459 (and optionally with non-conservative amino acid substitutions for S332, E336, R339, S359, and/or S411) are high rubber producing guayule.
- guayule encoding PaAos with conservative amino acid substitutions for D318, I408 and/or L459 (and optionally with or without conservative amino acid substitutions for S332, E336, R339, S359, and/or S411) are low rubber producing guayule. See Table 2 and preceding paragraph for information about conservative and non-conservative amino acid substitutions, and Table 1 for DNA codons for amino acids.
- the above described primers are used to determine if the indicated SNPs are present in the altered guayule seedling so that one does not need to grow the altered guayule for years before determining if the altered guayule is likely a high rubber producer or a low rubber producer.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
- This patent application claims priority to U.S. Patent Application 62/504,762 filed on May 11, 2017, contents of which are expressly incorporated by reference herein.
- The Sequence Listing submitted via EFS-Web as ASCII compliant text file format (.txt) filed on May 10, 2018, named “SequenceListing_ST25”, (created on May 9, 2018, 24 KB), is incorporated herein by reference. This Sequence Listing serves as paper copy of the Sequence Listing required by 37 C.F.R. § 1.821(c) and the Sequence Listing in computer-readable form (CRF) required by 37 C.F.R. § 1.821(e). A statement under 37 C.F.R. § 1.821(f) is not necessary.
- This invention relates to altered guayule plants that grow larger and produce more rubber than non-altered guayule plants, when grown under the same conditions. The altered guayule contain the cDNA sequence of Parthenium argentatum Allene oxide synthase (PaAos) in the reverse complement orientation under control of a heterologous promoter which reduces the production of PaAos via RNAi. Other types of genetic alternations can be made in guayule to reduce the functionality of PaAos. Kits for identifying such altered guayule, methods for identify the altered guayule, and methods of increasing rubber yield in guayule via reducing PaAos translation are also included.
- Natural rubber is synthesized by more than 2,500 plant species (Cornish, et al., J. Nat. Rubber Research 8:275-285 (1993); Cornish, K., Phytochemistry 57:1123-1134 (2001)). Rubber is produced by these plants as a secondary metabolite with no clear indication of its function in plant cells. Possible reasons on why these species synthesize rubber are to defend themselves against pathogens and insect attacks, repair tissue damages caused by mechanical wounding and protect cell damage induced by environmental stresses (Demel, et al., Biochim. Biophys. Acta. 1375:36-42 (1998); Tangpakdee and Tanaka, J. Rubber Res. 1:14 (1998); Vereyken, et al., Biochim. Biophys. Acta, 1510:307-320 (2001); Kim, et al., Plant Cell Physiol., 412-414 (2003) and references therein; Konno, K., Phytochemistry, 1510-1530 (2011); and Sarkar, J., Rubber Science, 228-237 (2013)). According to a 2014 market report, the rubber that these plants produce accounted for $16.5 billion in trade worldwide (rubberworld.com/RWmarket_report.asp). Even more so, the end products made from natural rubber, including tires for the transportation industry, sports equipment, medical devices, and more, are indispensable in our everyday life. The Hevea tree is the main source of natural rubber but concerns exist as it is limited geographically to tropical climates, mainly in Southeast Asia, is susceptible to diseases, and produces rubber that causes allergic reactions. Clearly, an alternative source for the production of natural rubber is very important to reduce economic risk and safeguard human health.
- One plant known to be a promising source of natural rubber is guayule (Parthenium argentatum, Gray), a desert shrub native to the southwestern United States and northern Mexico (Mooibroek and Cornish, Appl. Microbio. and Biochem. 53:355-365 (2000); van Beilen and Poirier, Critical Reviews Biotech. 27:217-231 (2007)). The majority of rubber synthesis in guayule occurs during the cold season. Guayule synthesizes rubber within subcellular organelles called rubber particles (Archer and Audley, Bot. J. Linnean Soc. 94:181-196 (1987)) stored in the parenchyma cells of stembark tissues (Gilliland, M. v., Protoplasma, 169-177 (1984)); Macrae, S. G., Plant Physiol., 1027-1032 (1986)). Natural rubber synthesis is initiated by the action of allylic pyrophosphates initiators (Cornish and Siler, J. Plant Physiol., 301-305 (1995)), usually farnesyl pyrophosphate (FPP). Then, the monomer isopentenyl-pyrophosphate (IPP), produced by the mevalonic acid pathway (MEV) in the cytosol and the methylerythritol phosphate (MEP) pathway in the plastid (Mooibroek and Cornish (2000); van Beilen and Poirier, TRENDS in Biotech., 522-529 (2007)) elongates the rubber chain. Rubber synthesis is mediated by rubber transferases requiring magnesium ions as cofactor (Da Costa, et al., Phytochemistry 67(15): 1621-1628 (2006)).
- The proposed model for the structure of rubber particles consists mostly of hydrophobic cis-polyisoprene units (natural rubber) encapsulated inside a protein and phospholipid surface monolayer (Nawamawat, et al., Colloids and Surfaces A: Physicochemical and Engineering Aspects, 390:157-166 (2011); Sansatsadeekul, et al., J. Biosci. and Bioeng, 111:628-634 (2011)). The phospholipids serve to stabilize and solubilize the otherwise insoluble (rubber) product. Guayule rubber particles include several proteins (Whalen, et al., Development of crops to produce industrially useful natural rubber. Chapter 23 in Isoprenoid Synthesis in Plants and Microorganisms: New Concepts and Experimental Approaches, Bach and Rohmer (eds.), DOI 10.1007/978-1-4614-4063-5_23, Springer Science+Business Media NY, 329-345 (2013)) of which Aos has been found to be the most abundant (Backhaus, et al., Phytochemistry 30:2493-2497 (1991)). Aos is well-known as an enzyme in the jasmonic acid biosynthetic pathway (Harms, et al., Plant Cell, 1645-1654 (1995); Wang, et al., Plant Mol. Biol., 783-793 (1999); Schaller, F., J. Exper. Botany, 11-23 (2001)). The role of Aos in rubber biosynthesis, and the reason for the abundance of Aos protein on guayule rubber particle surfaces, is not known (Whalen, et al. (2013)).
- The need exists for a method to increase rubber production in altered guayule compared to rubber production amounts in non-altered guayule in order to improve the commercial attractiveness of using guayule rubber as a replacement of synthetic rubber and Hevea rubber. Further, a need exists for increasing the rubber yield per acre obtained from altered guayule compared to the rubber yield per acre obtained from non-altered guayule. This greater rubber yield results from the altered guayule being larger in size than non-altered guayule of similar age. A need also exists for altered guayule that produce more rubber than the amount of rubber produced by non-altered guayule. A need also exists for altered guayule that have a larger size than similarly aged non-altered guayule because the altered guayule that are larger than the non-altered guayule will possess more tissue for storage of rubber and thus generate greater rubber yield per acre than the rubber yield per acre of wild-type guayule. And a need exists for biomarkers which distinguish between low rubber producing and high rubber producing guayules.
- It is an object of this invention to have altered guayule, parts of altered guayule, and progeny of the altered guayule, the altered guayule containing a mutation that causes the altered guayule to produce more rubber than the amount of rubber produced by a non-altered guayule. It is a further object of this invention that the mutation in the altered guayule can be one or more of (i) an alteration in a Parthenium argentatum Allene oxide synthase (PaAos) codon encoding an amino acid to a stop codon, (ii) an alteration of PaAos' translation initiation codon to another codon, (iii) an alteration in PaAos ribosome binding site's sequence, (iv) an alteration in one or more PaAos splice site codons, (v) a deletion of part or all of PaAos' sequence, (vi) an insertion of DNA into PaAos, and (vii) an alteration in one or more PaAos DNA codon sequences to encode a non-conservative amino acid. It is an object of this invention that each of these mutations reduces the altered PaAos' functionality compared to the amount of PaAos functionality in a non-altered guayule and that the reduced PaAos functionality causes the altered guayule to produce an increased amount of rubber compared to the amount of rubber produced by the non-altered guayule. It is another object of this invention that the alteration of one or more PaAos DNA codon sequences to encode a non-conservative amino acid occurs at amino acids located at 318, 332, 336, 339, 359, 408, 411, and 459 with PaAos' sequence (see SEQ ID NO: 10, 13, and 15). It is a further object of this invention that the amino acids being changed to non-conservative amino acids are D318, S332, E336, R339, S359, I408, S411, and/or L459. Another object of this invention is that the non-conservative amino acid substitutions are not N318, V408 and/or W459. It is another object of this invention to have an altered cell, germplasm, and an altered seed of the altered guayule, each containing the mutation.
- It is an object of this invention to have a method of producing an altered guayule that contains a mutated PaAos and produces more rubber compared to the amount of rubber produced by a non-altered guayule. It is another object of the invention that the method involves exposing a non-altered guayule cell or seed to a mutagen to produce a mutated guayule cell or seed with the mutated PaAos, selecting one or more of the mutated guayule cells or seeds containing the mutated PaAos which encodes an altered PaAos with reduced functionality compared to a non-altered PaAos's functionality, and growing the selected mutated guayule cell or seed containing the mutated PaAos to produce an altered guayule that produces the altered PaAos with reduced functionality and an increased amount of rubber compared to the amount of rubber produced by the non-altered guayule. It is another object of this invention that the mutated PaAos contains at least one of (i) an alteration of a PaAos codon encoding an amino acid to a stop codon, (ii) an alteration of PaAos' translation initiation codon to another codon, (iii) an alteration of PaAos ribosome binding site's sequence, (iv) an alteration of one or more PaAos splice site codons, (v) a deletion of part or all of PaAos' sequence, (vi) an insertion of DNA into PaAos, and (vii) an alteration of one or more PaAos codon sequences to encode a non-conservative amino acid. It is another object of this invention that the alteration of one or more PaAos codon sequences to encode a non-conservative amino acid occurs at amino acids located at 318, 332, 336, 339, 359, 408, 411, and 459 with PaAos' sequence (see SEQ ID NO: 10, 13, and 15). Another object of this invention is that the non-conservative amino acid substitutions are not N318, V408 and/or W459. It is another object of this invention to have an altered cell, germplasm, and an altered seed of the altered guayule produced by this method and each containing the mutation.
- It is an object of this invention to have a method for producing a population of high rubber producing guayule plants or seeds which contain PaAos with low functionality. It is an object of that method involves genotyping a first population of guayule plants or seeds that contain PaAos with low functionality, selecting from the first population one or more guayule plants or seeds containing PaAos with low functionality based the genotyping, and producing from the selected one or more guayule plants or seeds containing PaAos with low functionality a second population of guayule plants or seeds containing PaAos with low functionality. It is another object of this invention PaAos with low functionality contains at least one amino acid selected from group of N318, V408, W459, conservative amino acids substitutions thereof, and non-conservative amino acid substitutions at S332, E336, R339, S359, and S411.
- It is an object of this invention to have a method of identifying a high rubber producing guayule by detecting the presence of PaAos having amino acids N318, V408 and/or W459, or conservative amino acid substitution at one or more of these positions and/or having non-conservative amino acid substitutions at S332, E336, R339, S359, and S411 in a test guayule. It is further object of this invention that the method involves contacting the PaAos from the test guayule with monoclonal antibodies that binds to PaAos having the above mentioned amino acids, and determining if the monoclonal antibodies bind to the PaAos from the test guayule, where binding indicates the presence of the high rubber producing PaAos and no binding indicates the present of the low rubber producing PaAos. It is another object of this invention that the invention involves obtaining nucleic acids from the test guayule, performing a PCR assay with the obtained nucleic acids, a label, and primer sets SEQ ID NOs: 22 and 23, and SEQ ID NOs: 24 and 25, or similar sequences that encode conservative amino acid substitutions, and determining if an amplicon is generated; such that when an amplicon is produced, then the test guayule contains a PaAos nucleic acid sequence that encodes PaAos having amino acids N318, V408 and/or W459, or one or more of the conservative amino acid substitution at these positions, and/or non-conservative amino acid substitutions at S332, E336, R339, S359, and S411, and the test guayule is a high rubber producing guayule.
-
FIG. 1 shows the design of the plasmids used in Example 1 for the overexpression of PaAos (pND6-Aos), silencing of PaAos (pND6-AosiL), and for the control plasmid (pND6). Each expression vector features the NPTII gene to confer kanamycin resistance for selection, and the control plasmid contains the GUS (β-glucuronidase) reporter gene instead of PaAos or a portion of PaAos in reverse complementary orientation. Thus, one can use a histochemical GUS staining assay (the chromogenic substrate X-Gluc (C14H13BrCINO7)) as a visual indicator of transformed tissues with the negative control plasmid. -
FIG. 2 shows the primers used in the qRT-PCR, PCR reaction conditions, and the expected amplicon product size to determine RNA expression in the genetically altered guayule. Amplicon (mRNA product) PaAosOE is derived from plants transformed with pND6-Aos (Aos overexpression). Amplicon (mRNA product) PaAosRNAi is derived from plants transformed with pND6-AosiL (Aos silencing). Amplicon (mRNA product) 18S is from 18S ribosome RNA. Amplicon (mRNA product) PaAos is for wild-type guayule plants with intact PaAos gene. -
FIG. 3 provides size and weight measurements of the four types of guayule plants grown under different conditions in growth chambers. Plants are initially transferred to soil from tissue culture media and grown under greenhouse conditions for one month. Following, plants are moved to controlled-temperature growth chamber conditions under 27° C. (16 h)/25° C. (8 h) and at 27° C. (16 h)/10° C. (8 h). The four type of guayule plants are wild-type (G7-11.1 and G7-11.2), guayule transformed with the empty expression vector pND6 (pND6-10, pND6-12, pND6-35), guayule transformed with pND6-AosiL for silencing PaAos via RNAi (pND6-AosiL7-2, pND6-AosiL8-1, pND6-AosiL9-16, pND6-AosiL12-1,), and guayule transformed with pND6-Aos to overexpress PaAos (pND6-Aos4-1, pND6-Aos4-2, pND6-Aos5-1, pND6-Aos7-1,) at 2 months old. G7-11 is a breeder's nomenclature for what later became the USDA publicly released guayule Germplasm line AZ-2 (Reg. No. GP-9; PI 599676). The biomass of the shoot (leaves plus stems) and root are weighed in 2 months old guayule plants grown in growth chambers under 27° C. (16 h)/25° C. (8 h) and at 27° C. (16 h)/10° C. (8 h). The asterisks, (*), (**) and (***), indicate significant difference in comparison to (non-altered) G7-11 at p>0.05, 0.005 and 0.0005, respectively. -
FIG. 4 shows SPAD values indicating leaf chlorophyll concentration (“SPAD units”) for wild-type guayule (G7-11), guayule transformed with the empty expression vector (pND6); guayule transformed with pND6-Aos (Oe), and guayule transformed with pND6-AosiL (RNAi) grown at 27° C. (16 h)/25° C. (8 h) or 27° C. (16 h)/10° C. (8 h). -
FIG. 5 shows the number of branches and stem diameter of 2 months old genetically altered guayule (pND6-AosiL and pND6-Aos lines), non-altered guayule (G7-11) and empty vector control guayule (pND6) plants grown in growth chambers at 27° C. (16 h)/25° C. (8 h) or at 27° C. (16 h)/10° C. (8 h). pND6-AosiL genotypes have larger number of stems than the non-altered and empty vector controls. Additionally, the mature stembark tissues in pND6-AosiL have significantly thicker diameter (ranging from 35% to 54%) under both 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h). -
FIG. 6 shows results from gel permeation chromatography for elution of cyclohexane extractables from transformed and non-altered guayule plant lines. The natural rubber molecular weight is calculated using Astra software for three pND6-AosiL transformed guayule plants, three pND6-Aos transformed guayule plants, two pND6 transformed guayule plants, and non-altered guayule G7-11. The error bars represent 3 different plants with 3 technical replicates. -
FIG. 7 shows the relative expression of PaAos in guayule line G7-11, guayule line W6 549 (“W6549”), and guayule line PI 478652 (“478652”). -
FIG. 8A ,FIG. 8B , andFIG. 8C show single nucleotide polymorphisms (SNPs) in PaAos coding sequence for guayule cultivars W6 549 (“W6549”; SEQ ID NO: 12), G7-11 (SEQ ID NO: 9), and PI 478652 (“478652”; SEQ ID NO: 14). The SNPs are contained in boxes. -
FIG. 9 shows an alignment of PaAos amino acid sequences obtained from guayule cultivars W6 549 (“W6549”; SEQ ID NO: 13), PI 478652 (“478652”; SEQ ID NO: 15) and G7-11 (SEQ ID NO: 10). The boxes highlight the different amino acids in the cultivars. - This invention involves the discovery that a reduction in the amount of functional PaAos in guayule results in an increase in the amount of rubber produced. Further, different cultivars of guayule, having different DNA and amino acid sequences for PaAos and PaAos, respectively, produce different amounts of rubber. As such, one can distinguish between guayule cultivars that are “high” rubber producers and “low” rubber producers based on the differences in the DNA and/or amino acid sequence of PaAos and/or PaAos. Because single nucleotide polymorphisms (SNPs) exist in these different cultivars, one can use primers and PCR techniques to determine if any particular guayule is a “high” rubber producing guayule or a “low” rubber producing guayule. Alternatively, one can use antibodies that bind to the different PaAos proteins to determine if any particular guayule is a “high” rubber producer or a “low” rubber producer. As discussed below, guayule cultivar W6 549 has the lowest average rubber content (%) and
guayule cultivar PI 478652 has the highest average rubber content, among the tested cultivars. PaAos from both cultivars have slight differences in DNA sequences which, along with the differences in the amino acid sequences, can be used to determine if any particular cultivar is a high or low rubber producer. Any guayule that produces PaAos with conservative amino acid changes to SEQ ID NO: 15 is a high rubber producing guayule; any guayule that produces PaAos with conservative amino acid changes to SEQ ID NO: 13 is a low rubber producing guayule. Thus, one can screen plants for PaAos with conservative sequences to SEQ ID NO: 15 via DNA or protein assays. Alternatively, one screening for guayule with PaAos with the similar (or lower) level of functionality asguayule cultivar PI 478652's PaAos would identify a high rubber producing guayule; whereas screening for guayule with PaAos with a higher level of functionality would identify a low rubber producing guayule. - Because changes in PaAos functionality changes the amount of rubber produced by guayule, this invention also involves increasing a guayule's rubber production by reducing the amount of functional PaAos present in the genetically altered guayule (compared to the amount of functional PaAos present in non-altered guayule). In one embodiment, the genetically altered guayule has a mutation in PaAos, such as, a null mutation which results in (i) no protein is produced, (ii) a truncated protein is produced which has no functionality, or (iii) a full-length protein is produced which has no functionality. Other mutations simply reduce the functionality (activity) of PaAos. Non-limiting examples of mutations that reduce or eliminate PaAos functionality include (i) changing a codon encoding an amino acid to a stop codon (see Table 1 supra for the sequence of stop codons), (ii) changing the translation initiation codon (ATG) to any other codon to disrupt protein translation, (iii) changing a ribosome binding site's sequence to disrupt protein translation, (iv) changing one or more splice site codons to alter protein sequence, (v) deleting some or all of the gene's DNA sequence, (vi) inserting DNA into the gene, and (vii) changing one or more DNA codon sequences to encode non-conservative amino acids. Within SEQ ID NO: 9, nucleotides 34-36 encode ATG, the translation initiation codon for G7-11 guayule. Similarly, nucleotides 1-3 of SEQ ID NOs: 12 and 14 encode ATG, the translation initiation codon for
cultivars PI 478652 and W6549, respectfully. Thus, a change in the nucleotide sequence of the equivalent codon in any other guayule would have the same result. Within PaAos, non-conservative amino acid substitutions at D318, S332, E336, R339, S359, I408, S411, and/or L459 (to name a few) result in PaAos with reduced functionality. One alters guayule DNA using the methods described herein and assesses changes in PaAos functionality via the methods described herein (e.g., assessing the amount of rubber produced by the altered guayule) or using methods known to one of ordinary skill in the art. One can utilize SNPs, antibodies, and other methods to identify the guayule that encode the altered amino acids. When no functional PaAos is produced or when PaAos with reduced functionality is produced, then it is understood that the altered guayule produces “a reduced amount of functional PaAos”. Such altered guayule producing a reduced amount of functional PaAos is another embodiment of this invention. - Because this invention involves production of genetically altered plants and involves recombinant DNA techniques, the following definitions are provided to assist in describing this invention. The terms “isolated”, “purified”, or “biologically pure” as used herein, refer to material that is substantially or essentially free from components that normally accompany the material in its native state or when the material is produced. In an exemplary embodiment, purity and homogeneity are determined using analytical chemistry techniques such as polyacrylamide gel electrophoresis or high performance liquid chromatography. A nucleic acid or particular bacteria that are the predominant species present in a preparation is substantially purified. In an exemplary embodiment, the term “purified” denotes that a nucleic acid or protein that gives rise to essentially one band in an electrophoretic gel. Typically, isolated nucleic acids or proteins have a level of purity expressed as a range. The lower end of the range of purity for the component is about 60%, about 70% or about 80% and the upper end of the range of purity is about 70%, about 80%, about 90% or more than about 90%.
- The term “gene” refers to a DNA sequence involved in producing a RNA or polypeptide or precursor thereof. The polypeptide or RNA is encoded by a full-length coding sequence (cds) or by intron-interrupted portions of the coding sequence, such as exon sequences. In one embodiment of this invention, the gene involved is Parthenium argentatum allene oxide synthase (PaAos or Aos). PaAos cDNA and amino acid sequence is found in GenBank accession number X78166.2 which is cultivar G7-11 (wild-type/non-altered) (USDA publicly released guayule Germplasm line AZ-2 (Reg. No. GP-9; PI 599676)). The cDNA sequence is in SEQ ID NO: 9; the protein sequence is in SEQ ID NO: 10. SEQ ID NO: 12 is the cDNA sequence for PaAos and SEQ ID NO: 13 is the amino acid sequence for PaAos in guayule W6549 cultivar. SEQ ID NO: 14 is the cDNA sequence for PaAos and SEQ ID NO: 15 is the amino acid sequence for PaAos in
guayule 478652 cultivar. A molecular marker uses SNPs within PaAos to differentiate the cultivars with differences in PaAos amino acid sequences which result in PaAos with different functionalities. - The term “nucleic acid” as used herein, refers to a polymer of ribonucleotides or deoxyribonucleotides. Typically, “nucleic acid” polymers occur in either single- or double-stranded form, but are also known to form structures comprising three or more strands. The term “nucleic acid” includes naturally occurring nucleic acid polymers as well as nucleic acids comprising known nucleotide analogs or modified backbone residues or linkages, which are synthetic, naturally occurring, and non-naturally occurring, which have similar binding properties as the reference nucleic acid, and which are metabolized in a manner similar to the reference nucleotides. Exemplary analogs include, without limitation, phosphorothioates, phosphoramidates, methyl phosphonates, chiral-methyl phosphonates, 2-O-methyl ribonucleotides, peptide-nucleic acids (PNAs). “DNA”, “RNA”, “polynucleotides”, “polynucleotide sequence”, “oligonucleotide”, “nucleotide”, “nucleic acid”, “nucleic acid molecule”, “nucleic acid sequence”, “nucleic acid fragment”, and “isolated nucleic acid fragment” are used interchangeably herein.
- For nucleic acids, sizes are given in either kilobases (kb) or base pairs (bp), or nucleotides (nt). Estimates are typically derived from agarose or acrylamide gel electrophoresis, from sequenced nucleic acids, or from published DNA sequences. For proteins, sizes are given in kiloDaltons (kDa) or amino acid residue numbers. Proteins sizes are estimated from gel electrophoresis, from sequenced proteins, from derived amino acid sequences, or from published protein sequences.
- Unless otherwise indicated, a particular nucleic acid sequence for each amino acid substitution (alteration) also implicitly encompasses conservatively modified variants thereof (e.g., degenerate codon substitutions), the complementary (or complement) sequence, and the reverse complement sequence, as well as the sequence explicitly indicated. Specifically, degenerate codon substitutions may be achieved by generating sequences in which the third position of one or more selected (or all) codons is substituted with mixed-base and/or deoxyinosine residues (see e.g., Batzer et al., Nucleic Acid Res. 19:5081 (1991); Ohtsuka et al., J. Biol. Chem. 260:2605-2608 (1985); and Rossolini et al., Mol. Cell. Probes 8:91-98(1994)). Because of the degeneracy of nucleic acid codons, one can use various different polynucleotides to encode identical polypeptides. Table 1, infra, contains information about which nucleic acid codons encode which amino acids and is useful for determining the possible nucleotide substitutions that are included in this invention.
-
TABLE 1 Amino acid Nucleic acid codons Ala/A GCT, GCC, GCA, GCG Arg/R CGT, CGC, CGA, CGG, AGA, AGG Asn/N AAT, AAC Asp/D GAT, GAC Cys/C TGT, TGC Gln/Q CAA, CAG Glu/E GAA, GAG Gly/G GGT, GGC, GGA, GGG His/H CAT, CAC Ile/I ATT, ATC, ATA Leu/L TTA, TTG, CTT, CTC, CTA, CTG Lys/K AAA, AAG Met/M ATG Phe/F TTT, TTC Pro/P CCT, CCC, CCA, CCG Ser/S TCT, TCC, TCA, TCG, AGT, AGC Thr/T ACT, ACC, ACA, ACG Trp/W TGG Tyr/Y TAT, TAC Val/V GTT, GTC, GTA, GTG Stop TAA, TGA, TAG - In addition to the degenerate nature of the nucleotide codons which encode amino acids, alterations in a polynucleotide that result in the production of a chemically equivalent amino acid at a given site, but do not affect the functional properties of the encoded polypeptide, are well known in the art. “Conservative amino acid substitutions” are those substitutions that are predicted to interfere least with the properties of the reference polypeptide. In other words, conservative amino acid substitutions substantially conserve the structure and the function of the reference protein. Thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine or histidine, is also expected to produce a functionally equivalent protein or polypeptide. Table 2 provides a list of exemplary conservative amino acid substitutions. Conservative amino acid substitutions generally maintain (a) the structure of the polypeptide backbone in the area of the substitution, for example, as a beta sheet or alpha helical conformation, (b) the charge or hydrophobicity of the molecule at the site of the substitution, and/or (c) the bulk of the side chain. In another embodiment, groups of amino acids that are conservative substitutions for each other are (i) alanine (Ala or A), serine (Ser or S), and threonine (Thr or T); (ii) aspartic acid (Asp or D) and glutamic acid (Glu or E); (iii) asparagine (Asn or N) and glutamine (Gln or Q); (iv) arginine (Arg or R) and lysine (Lys or K); (v) isoleucine (Ile or I), leucine (Leu or L), methionine (Met or M), and valine (Val or V); and (vi) phenylalanine (Phe or F), tyrosine (Tyr or Y), and tryptophan (Trp or W). See, Creighton, Proteins, W.H. Freeman and Co. (1984), contents of which are expressly incorporated herein. In yet another embodiment, amino acid(s) that are conservative substitutes for one amino acid are grouped by the following characteristics: aliphatic amino acids (alanine, glycine, isoleucine, leucine, and valine); hydroxyl or sulfur containing amino acids (cysteine, serine, methionine, and threonine); cyclic (proline); aromatic (phenylalanine, tryptophan, and tyrosine); basic (arginine, histidine, and lysine); acidic (aspartate and glutamate); and uncharged (asparagine and glutamine). As discussed below, wild-type guayule can be “high” rubber producers or “low” rubber producers. In both types of guayule, there are several amino acid changes in PaAos that be used to distinguish the “high” and “low” rubber producers. As such, one may change DNA encoding one, two, or more of the amino acids to change a “low” rubber producing guayule into a “high” rubber producing guayule. Alternatively, one may change the DNA to encode an amino acid that is a conservative substitute (per Table 2) of the one, two, or more amino acids different in the “high” rubber producing guayule. Further, because the “high” rubber producing guayule discussed below have several amino acids different in PaAos than the “low” rubber producing guayule, the invention also includes any conservative amino acids changes that can be made in these one, two, or more amino acids.
-
TABLE 2 Amino Acid Conservative Substitute Ala Gly, Ser Arg His, Lys Asn Asp, Gln, His Asp Asn, Glu Cys Ala, Ser Gln Asn, Glu, His Glu Asp, Gln, His Gly Ala His Asn, Arg, Gln, Glu Ile Leu, Val Leu Ile, Val Lys Arg, Gln, Glu Met Ile, Leu Phe His, Leu, Met, Trp, Tyr Ser Cys, Thr Thr Ser, Val Trp Phe, Tyr Tyr His, Phe, Trp Val Ile, Leu, Thr - The term “primer” refers to an oligonucleotide which may act as a point of initiation of DNA extension. A primer may occur naturally, as in a purified restriction digest, or may be produced synthetically.
- A primer is selected to be “substantially complementary” to a strand of specific sequence of the template. A primer must be sufficiently complementary to hybridize with a template strand for primer elongation to occur. A primer sequence need not reflect the exact sequence of the template. For example, a non-complementary nucleotide fragment may be attached to the 5′ end of the primer, with the remainder of the primer sequence being substantially complementary to the strand. Non-complementary bases or longer sequences can be interspersed into the primer, provided that the primer sequence is sufficiently complementary with the sequence of the template to hybridize and thereby form a template primer complex for synthesis of the extension product of the primer.
- Oligonucleotides and polynucleotides that are not commercially available can be chemically synthesized e.g., according to the solid phase phosphoramidite triester method first described by Beaucage and Caruthers, Tetrahedron Letts. 22:1859-1862 (1981), or using an automated synthesizer, as described in Van Devanter et al., Nucleic Acids Res. 12:6159-6168 (1984). Other methods for synthesizing oligonucleotides and polynucleotides are known in the art. Purification of oligonucleotides is by either native acrylamide gel electrophoresis or by anion-exchange HPLC as described in Pearson & Reanier, J. Chrom. 255:137-149 (1983).
- The terms “identical” or percent “identity”, in the context of two or more polynucleotides or polypeptide sequences, refer to two or more sequences or sub-sequences that are the same or have a specified percentage of nucleotides or amino acids (respectively) that are the same (e.g., 80%, 85% identity, 90% identity, 99%, or 100% identity), when compared and aligned for maximum correspondence over a designated region as measured using a sequence comparison algorithm or by manual alignment and visual inspection.
- The phrase “high percent identical” or “high percent identity”, in the context of two polynucleotides or polypeptides, refers to two or more sequences or sub-sequences that have at least about 80%, identity, at least about 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% nucleotide or amino acid identity, when compared and aligned for maximum correspondence, as measured using a sequence comparison algorithm or by visual inspection. In an exemplary embodiment, a high percent identity exists over a region of the sequences that is at least about 16 nucleotides or amino acids in length. In another exemplary embodiment, a high percent identity exists over a region of the sequences that is at least about 50 nucleotides or amino acids in length. In still another exemplary embodiment, a high percent identity exists over a region of the sequences that is at least about 100 nucleotides or amino acids or more in length. In one exemplary embodiment, the sequences are high percent identical over the entire length of the polynucleotide or polypeptide sequences.
- For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters may be used, or alternative parameters designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters. Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison is conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Natl. Acad. Sci. USA 85:2444 (1988), by computerized implementations of various algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), and/or by manual alignment and visual inspection (see, e.g., Ausubel et al. (eds.), Current Protocols in Molecular Biology, 1995 supplement).
- The “complement” of a particular polynucleotide sequence is that nucleotide sequence which would be capable of forming a double-stranded DNA or RNA molecule with the represented nucleotide sequence, and which is derived from the represented nucleotide sequence by replacing the nucleotides by their complementary nucleotide according to Chargaff's rules (A< >T; G< >C) and reading in the 5′ to 3′ direction, i.e., in opposite direction of the represented nucleotide sequence (reverse complement).
- In one embodiment of the invention, sense and antisense RNAs and dsRNA can be separately expressed in-vitro or in-vivo. In-vivo production of sense and antisense RNAs may use different chimeric polynucleotide constructs using the same or different promoters or using an expression vector containing two convergent promoters in opposite orientation. The sense and antisense RNAs which are formed (e.g., in the same host cells or synthesized) then combine to form dsRNA. To be clear, whenever reference is made herein to a dsRNA chimeric or fusion polynucleotide or a dsRNA molecule, that such dsRNA formed (e.g., in plant cells) from sense and antisense RNA produced separately is also included. Also, synthetically made dsRNA and self-annealing RNA strands are included herein when the sense and antisense strands are present together.
- As used herein, the term “promoter” refers to a polynucleotide that, in its native state, is located upstream or 5′ to a translational start codon of an open reading frame (or protein-coding region) and that is involved in recognition and binding of RNA polymerase and other proteins (trans-acting transcription factors) to initiate transcription. A “plant promoter” is a native or non-native promoter that is functional in plant cells, even if the promoter is present in a microorganism that infects plants or a microorganism that does not infect plants. The promoters that are predominately functional in a specific tissue or set of tissues are considered “tissue-specific promoters”. A plant promoter can be used as a 5′ regulatory element for modulating expression of a particularly desired polynucleotide (heterologous polynucleotide) operably linked thereto. When operably linked to a transcribable polynucleotide, a promoter typically causes the transcribable polynucleotide to be transcribed in a manner that is similar to that of which the promoter is normally associated.
- Plant promoters include promoters produced through the manipulation of known promoters to produce artificial, chimeric, or hybrid promoters. Such promoters can also combine cis-elements from one or more promoters, for example, by adding a heterologous regulatory element to an active promoter with its own partial or complete regulatory elements. The term “cis-element” refers to a cis-acting transcriptional regulatory element that confers an aspect of the overall control of gene expression. A cis-element may function to bind transcription factors, trans-acting protein factors that regulate transcription. Some cis-elements bind more than one transcription factor, and transcription factors may interact with different affinities with more than one cis-element.
- The term “vector” refers to DNA, RNA, a protein, or polypeptide that are to be introduced into a host cell or organism. The polynucleotides, protein, and polypeptide which are to be introduced into a host may be therapeutic or prophylactic in nature; may encode or be an antigen; may be regulatory in nature; etc. There are various types of vectors including viruses, viroids, plasmids, bacteriophages, cosmids, and bacteria.
- An expression vector is nucleic acid capable of replicating in a selected host cell or organism. An expression vector can replicate as an autonomous structure, or alternatively integrate, in whole or in part, into the host cell chromosomes or the nucleic acids of an organelle, or it is used as a shuttle for delivering foreign DNA to cells, and thus replicate along with the host cell genome. Thus, an expression vector are polynucleotides capable of replicating in a selected host cell, organelle, or organism, e.g., a plasmid, virus, artificial chromosome, nucleic acid fragment, and for which certain genes on the expression vector (including genes of interest) are transcribed and translated into a polypeptide or protein within the cell, organelle or organism; or any suitable construct known in the art, which comprises an “expression cassette”. In contrast, as described in the examples herein, a “cassette” is a polynucleotide containing a section of an expression vector. The use of the cassettes assists in the assembly of the expression vectors. An expression vector is a replicon, such as plasmid, phage, virus, chimeric virus, or cosmid, and which contains the desired polynucleotide sequence operably linked to the expression control sequence(s).
- A heterologous polynucleotide sequence is operably linked to one or more transcription regulatory elements (e.g., promoter, terminator and, optionally, enhancer) such that the transcription regulatory elements control and regulate the transcription and/or translation of that heterologous polynucleotide sequence. A cassette has the heterologous polynucleotide operably linked to one or more transcription regulatory elements. As used herein, the term “operably linked” refers to a first polynucleotide, such as a promoter, connected with a second transcribable polynucleotide, such as a gene of interest, where the polynucleotides are arranged such that the first polynucleotide affects the transcription of the second polynucleotide. In some embodiments, the two polynucleotide molecules are part of a single contiguous polynucleotide. In other embodiments, the two polynucleotides are adjacent. For example, a promoter is operably linked to a gene of interest if the promoter regulates or mediates transcription of the gene of interest in a cell. Similarly, a terminator is operably linked to the polynucleotide of interest if the terminator regulates or mediates transcription of the polynucleotide of interest, and in particular, the termination of transcription. Constructs of the present invention would typically contain a promoter operably linked to a transcribable polynucleotide operably linked to a terminator.
- The term “recombinant” when used with reference, e.g., to a cell, or nucleic acid, protein, or vector, indicates that the cell, organism, nucleic acid, protein or vector, has been altered by the introduction of a heterologous nucleic acid or protein or the alteration of a native nucleic acid or protein, or that the cell is derived from a cell so altered. Thus, for example, recombinant cells may express genes/polynucleotides that are not found within the native (non-recombinant or non-altered or wild-type) form of the cell or express native genes in an otherwise abnormal amount—over-expressed, under-expressed or not expressed at all—compared to the non-altered cell or organism. In particular, one alters the genomic DNA of a non-altered plant by molecular biology techniques that are well-known to one of ordinary skill in the art and generate a recombinant plant.
- The terms “transgenic”, “transformed”, “transformation”, and “transfection” are similar in meaning to “recombinant” “Transformation”, “transgenic”, and “transfection” refer to the transfer of a polynucleotide into a host organism or into a cell. Such a transfer of polynucleotides may result in genetically stable inheritance of the polynucleotides or in the polynucleotides remaining extra-chromosomally (not integrated into the chromosome of the cell). Genetically stable inheritance may potentially require the transgenic organism or cell to be subjected for a period of time to one or more conditions which require the transcription of some or all of the transferred polynucleotide in order for the transgenic organism or cell to live and/or grow. Polynucleotides that are transformed into a cell but are not integrated into the host's chromosome remain as an expression vector within the cell. One may need to grow the cell under certain growth or environmental conditions in order for the expression vector to remain in the cell or the cell's progeny. Further, for expression to occur the organism or cell may need to be kept under certain conditions. Genetically altered organisms or cells containing the recombinant polynucleotide are referred to as “transgenic” or “transformed” organisms or cells or simply as “transformants”, as well as recombinant organisms or cells.
- A genetically altered organism is any organism with any changes to its genetic material involving the invention described herein, whether in the nucleus or cytoplasm (organelle). As such, a genetically altered organism may be a recombinant or transformed organism. A genetically altered organism may also be an organism that was subjected to one or more mutagens or the progeny of an organism that was subjected to one or more mutagens and has mutations in its DNA caused by the one or more mutagens, as compared to the wild-type organism (i.e., organism not subjected to the mutagens) or the non-altered organism (i.e., one that contains alterations that are not the subject matter of this invention). Also, an organism that has been bred to incorporate a mutation into its genetic material is a genetically altered organism.
- The term “altered” means that a change occurred compared to the “non-altered” item. However, a “non-altered” item could contain changes that are induced by man, but those changes are not the subject matter of the inventions described herein. For example, a non-altered guayule contains none of the described genetic changes nor has been treated with any of the described external substance, but may contain pre-existing changes which are not part of this invention. An altered guayule (which also is a genetically altered guayule) may contain DNA mutations which change PaAos' amino acid sequence, even if that sequence exists in a non-altered plant. Such DNA mutations may be induced by a mutagen (EMS, UV light, other radiation, etc.).
- Transformation and generation of genetically altered monocotyledonous and dicotyledonous plant cells is well known in the art. See, e.g., Weising, et al., Ann. Rev. Genet. 22:421-477 (1988); U.S. Pat. No. 5,679,558; Agrobacterium Protocols, ed: Gartland, Humana Press Inc. (1995); and Wang, et al. Acta Hort. 461:401-408 (1998). A method to generate genetically altered guayule is described in U.S. Pat. No. 9,018,449 (Dong & Cornish) and in Dong, et al., Plant Cell Reports 25:26-34 (2006). A method to generate transplastomic guayule is provided in U.S. Patent Application Publication 2014/0325699, contents of which are expressly incorporated herein. The choice of method varies with the type of plant to be transformed, the particular application and/or the desired result. The appropriate transformation technique is readily chosen by the skilled practitioner.
- A polynucleotide encoding PaAos (SEQ ID NOs: 9, 12, and/or 14), the reverse complement of PaAos, or a portion thereof (e.g., SEQ ID NO: 11), operably linked to one or two appropriate promoters, can be stably inserted in a conventional manner into the genome (cytoplasmic genome or nucleic genome) of a single plant cell, and the altered plant cell can be used in a conventional manner to produce a genetically altered plant that produces the dsRNA of this invention. In this regard, a disarmed Ti-plasmid, containing the polynucleotide of this invention, in Agrobacterium tumefaciens can be used to genetically alter the plant cell, and thereafter, a genetically altered plant can be regenerated from the genetically altered plant cell using the procedures described in the art, for example, in
EP 0 116 718,EP 0 270 822, WO 84/02913 andEP 0 242 246. Plant regeneration from cultured protoplasts is described in Evans et al., Protoplasts Isolation and Culture, in Handbook of Plant Cell Culture, pp. 124-176, MacMillan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, in Plant Protoplasts, pp. 21-73, CRC Press, Boca Raton, 1985. Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee, et al., Ann. Rev. of Plant Phys. 38:467-486 (1987). - Preferred Ti-plasmid vectors each contain the polynucleotides described herein between the border sequences, or at least located to the left of the right border sequence, of the T-DNA of the Ti-plasmid. Of course, other types of vectors may be used to transform the plant cell, using procedures such as direct gene transfer (as described, for example in
EP 0 233 247), pollen mediated transformation (as described, for example inEP 0 270 356, WO 85/01856, and U.S. Pat. No. 4,684,611), plant RNA virus-mediated transformation (as described, for example inEP 0 067 553 and U.S. Pat. No. 4,407,956), liposome-mediated transformation (as described, for example in U.S. Pat. No. 4,536,475), and other methods such as the methods for transforming certain lines of corn (e.g., U.S. Pat. No. 6,140,553; Fromm, et al., Bio/Technology 8:833-839 (1990); Gordon-Kamm, et al., The Plant Cell 2:603-618 (1990) and rice (Shimamoto, et al., Nature 338:274-276 (1989); Datta et al., Bio/Technology 8:736-740 (1990)) and the method for transforming monocots generally (WO 92/09696). For cotton transformation, the method described in WO 2000/71733 can be used. For soybean transformation, reference is made to methods known in the art, e.g., Hinchee, et al. (Bio/Technology 6:915 (1988)) and Christou, et al. (Trends Biotechnology 8:145 (1990)) or the method of WO 00/42207. - The resulting genetically altered plant can be used in a conventional plant breeding scheme to produce more genetically altered plants with the same characteristics or to introduce the polynucleotide into other varieties of the same or related plant species. Seeds, which are obtained from the genetically altered plants, contain the expression vector as a stable genomic insert. Altered plants include plants having or derived from root stocks of plants containing the expression vector. Hence, any non-altered grafted plant parts inserted on a genetically altered plant or plant part are included in the invention.
- For a genetically altered plant that produces dsRNA, one constructs an expression vector or cassette (made from DNA) that encodes, at a minimum, a first promoter and the dsRNA sequence of interest such that the promoter sequence is 5′ (upstream) to and operably linked to the dsRNA sequence. The expression vector or cassette may optionally contain a second promoter (same as or different from the first promoter) upstream and operably linked to the reverse complementary sequence of the dsRNA sequence such that two strands of RNA that are complementary to each other are produced. Alternatively, the expression vector or cassette can contain one promoter operably linked to both the dsRNA sequence (sense strand) in question and the complement or reverse complement of the dsRNA sequence (anti-sense strand) in question, such that the transcribed RNA bends on itself and the two desires sequences anneal. Alternatively, a second expression vector or cassette (made from DNA) may encode, at a minimum, a second promoter (same as or different from the promoter) operably linked to the reverse complementary sequence of the dsRNA such that two strands of complementary RNA are produced in the plant. The expression vector(s) or cassette(s) is/are inserted in a plant cell genome (nuclear or cytoplasmic). The promoter(s) used should be a promoter(s) that is/are active in a plant and is/are heterologous to PaAos (not normally driving the transcription of RNA of genomic PaAos). Of course, the expression vector or cassette may have other transcription regulatory elements, such as enhancers, terminators, etc.
- Promoters (and more specifically, heterologous promoters for PaAos) that are active in plants are well-known in the field. Such promoters may be constitutive, inducible, and/or tissue-specific. Non-limiting examples of constitutive plant promoters include 35S promoters of the cauliflower mosaic virus (CaMV) (e.g., of isolates CM 1841 (Gardner, et al., Nucleic Acids Research 9:2871-2887 (1981)), CabbB-S (Franck, et al., Cell 21:285-294 (1980)) and CabbB-JI (Hull and Howell, Virology 86:482-493 (1987))), ubiquitin promoter (e.g., the maize ubiquitin promoter of Christensen, et al., Plant Mol. Biol. 18:675-689 (1992)), gos2 promoter (de Pater, et al., The Plant J. 2:834-844 (1992)), emu promoter (Last, et al., Theor. Appl. Genet. 81:581-588 (1990)), actin promoter (see, e.g., An, et al., The Plant J. 10:107 (1996)) and Zhang, et al., The Plant Cell 3:1155-1165 (1991)); Cassava vein mosaic virus promoters (see, e.g., WO 97/48819 and Verdaguer, et al., Plant Mol. Biol. 37:1055-1067 (1998)), the pPLEX series of promoters from Subterranean Clover Stunt Virus (WO 96/06932, particularly the S4 or S7 promoter), alcohol dehydrogenase promoter (e.g., pAdh1S (GenBank accession numbers X04049, X00581)), and the TR1′ promoter and the TR2′ promoter which drive the expression of the 1′ and 2′ genes, respectively, of the T-DNA (Velten, et al., EMBO J. 3:2723-2730 (1984)). Tissue-specific promoters are promoters that direct a greater level of transcriptional expression in some cells or tissues of the plant than in other cells or tissue. Non-limiting examples of tissue-specific promoters include the phosphoenolpyruvate carboxylase (PEP or PPC1) promoter (Pathirana, et al., Plant J. 12:293-304 (1997), and Kausch, et al., Plant Mol. Biol. 45(1):1-15 (2001)), chlorophyll A/B binding protein (CAB) promoter (Bansal, et al., Proc. Natl. Acad. Sci. USA 89(8):3654-8 (1992)), small subunit of ribulose-1,5-bisphosphate carboxylase (ssRBCS) promoter (Bansal, et al., Proc. Natl. Acad. Sci. USA 89(8):3654-8 (1992)), senescence activated promoter (SEE1) (Robson, et al., Plant Biotechnol. J. 2(2):101-12 (2004)), and sorghum leaf primoridia specific promoter (RS2) (GenBank Accession No. E1979305.1). These promoters (PPC1, CAB, ssRBCS, SSE1, and RS2) are all active in the aerial part of a plant. Further, the PPC1 promoter is a strong promoter for expression in vascular tissue. Some examples of phloem specific promoters are the sucrose synthase-1 promoters (CsSUS1p and CsSUS1p-2) (Singer et al., Planta 234:623-637 (2011)) and the phloem protein-2 promoter (CsPP2) (Miyata et al., Plant Cell Report 31(11):2005-2013 (2012)) from Citrus sinensis. Alternatively, a plant-expressible promoter may also be a wound-inducible promoter, such as the promoter of the pea cell wall invertase gene (Zhang, et al., Plant Physiol. 112:1111-1117 (1996)).
- Other types of RNA polymerase promoters that may be used are promoters from microorganisms, such as, but not limited to the bacteriophage T7 RNA polymerase promoter, yeast Galactose (GAL1) promoter, yeast glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter, yeast Alcohol Oxidase (AOX) promoter.
- Other elements used to increase transcription expression in plant cells include, but are not limited to, an intron (e.g., hsp70 intron) at the 5′ end or 3′ end of the chimeric gene, or in the coding sequence of the chimeric dsRNA gene (such as, between the region encoding the sense and antisense portion of the dsRNA), promoter enhancer elements, duplicated or triplicated promoter regions, 5′ leader sequences different from the chimeric gene or different from an endogenous (plant host) gene leader sequence, 3′ untranslated sequences different from the chimeric gene or different from an endogenous (plant host) 3′ untranslated sequence.
- The expression vector or cassette could contain suitable 3′ untranslated transcription regulation sequences (i.e., transcript formation and polyadenylation sequences). Potential polyadenylation and transcript formation sequences include those sequences in the nopaline synthase gene (Depicker, et al., J. Molec. Appl. Genetics 1:561-573 (1982)), the octopine synthase gene (Gielen, et al., EMBO J. 3:835-845 (1984)), the SCSV or the Malic enzyme terminators (Schunmann, et al., Plant Functional Biology 30:453-460 (2003)), and the T-DNA gene 7 (Velten and Schell, Nucleic Acids Research 13:6981-6998 (1985)).
- The term “plant” includes whole plants, plant organs, progeny of whole plants or plant organs, embryos, somatic embryos, embryo-like structures, protocorms, protocorm-like bodies (PLBs), and suspensions of plant cells. Plant organs comprise, e.g., shoot vegetative organs/structures (e.g., leaves, stems and tubers), roots, flowers and floral organs/structures (e.g., bracts, sepals, petals, stamens, carpels, anthers and ovules), seed (including embryo, endosperm, and seed coat) and fruit (the mature ovary), plant tissue (e.g., vascular tissue, ground tissue, and the like) and cells (e.g., guard cells, egg cells, trichomes and the like). The class of plants that can be used in the method of the invention is generally as broad as the class of higher and lower plants amenable to the molecular biology and plant breeding techniques described herein, specifically angiosperms (monocotyledonous (monocots) and dicotyledonous (dicots) plants). It includes plants of a variety of ploidy levels, including aneuploid, polyploid, diploid, haploid and hemizygous. The genetically altered plants described herein are guayule plants.
- Rubber yield may be expressed as a product of rubber content (% rubber) and biomass (dry weight/unit area). Thus, rubber yield may be improved by increasing either biomass and/or rubber content. The altered guayule described herein produce more rubber and have higher rubber content than non-altered guayule, thereby increasing the processing efficiency of the guayule shrub.
- Various methods exist to create a mutation. These methods are well-known to one of ordinary skill in the art. One method is by transforming the plant with a plasmid containing 5′ sequence and 3′ sequence of the gene and allowing a cross-over event to occur, thereby excising the DNA from the plant's genome that is between the plasmid's 5′ sequence and 3′ sequence. Also, one can use transposon-mediated mutation to delete or add DNA to PaAos which would result in the encoded protein having a reduced functionality compared to a non-altered PaAos. Two other methods involve using a chemical mutagen (such as ethyl methanesulfonate (EMS)) or physical agents (radiation, UV, or proton, for example) to generate genetic mutations in plant cells and/or germplasm. Also, one may use TALEN or CRISPR-Cas9 to mutate the sequence of the target gene (PaAos) such that a desired mutation is generated. One of ordinary skill in the art can also use targeted cleavage events to induce targeted mutagenesis, induce targeted deletions of cellular DNA sequences, and facilitate targeted recombination and integration at predetermined chromosomal locations to generate one or more of the null mutations discussed above or to reduce the mutated protein's functionality. Nucleotide editing techniques are well-known and described in Urnov, et al., Nature 435(7042):646-51 (2010); U.S. Patent Publications 2003/0232410, 2005/0208489, 2005/0026157, 2005/0064474, 2006/0188987, 2009/0263900, 2009/0117617, 2010/0047805, 2011/0207221, 2011/0301073, 2011/089775, 2011/0239315, and 2011/0145940; and International Publication WO 2007/014275, the disclosures of which are incorporated by reference in their entireties for all purposes. Cleavage occurs by using specific nucleases such as engineered zinc finger nucleases (ZFN), transcription-activator like effector nucleases (TALENs), or using the CRISPR/Cas9 system with an engineered crRNA/tracr RNA (‘single guide RNA’) to guide specific cleavage. U.S. Patent Publication 2008/0182332 describes the use of non-canonical zinc finger nucleases (ZFNs) for targeted modification of plant genomes; U.S. Patent Publication 2009/0205083 describes ZFN-mediated targeted modification of a plant EPSPS locus; U.S. Patent Publication 2010/0199389 describes targeted modification of a plant Zp15 locus and U.S. Patent Publication No. 20110167521 describes targeted modification of plant genes involved in fatty acid biosynthesis. In addition, Moehle, et al., Proc. Natl. Acad. Sci. USA 104(9):3055-3060 (2007) describes using designed ZFNs for targeted gene addition at a specified locus. U.S. Patent Publication 2011/0041195 describes methods of making homozygous diploid organisms. Information on CRISPR/Cas9 system is found, e.g., at en.wikipedia.org/wiki/CRISPR; neb.com/tools-and-resources/feature-articles/crispr-cas9-and-targeted-genome-editing-a-new-era-in-molecular-biology; and Cong, et al., Science, 339:819-823 (2013). Sigma-Aldrich (St. Louis, Mo.) and Origene Technologies, Inc. (Rockville, Md.) are among the companies that sell CRISPR/Cas9 kits.
- After using any of these various methods to induce genetic alterations in a cell's genome, one induces the treated cells to grow into plants and then screen the plants using the methods described herein for PaAos having reduced or no functionality, and/or for reduced amounts of PaAos or no PaAos (via reduction in gene expression and/or mRNA translation and/or other mechanism), and/or for elevated production of rubber (compared to amounts present in non-altered plants). Thus, another embodiment of this invention is the generation of altered guayule having a genetic alteration in PaAos such that the altered guayule produces more rubber than produced by non-altered guayule.
- In another embodiment, one synergistically increases the amount of rubber produced by exposing an altered guayule to cold temperatures (between approximately 7° C. and approximately 15° C. or between approximately 10° C. and approximately 15° C.; approximately 8 hours per day) for approximately two weeks or more. The altered guayule may contain one of more of the following alterations: (1) DNA encoding (i) anti-sense RNA for PaAos, (ii) double-stranded RNA for PaAos, (iii) a mutation within PaAos that encodes a PaAos with reduced or no function; and/or (2) exogenously administered PaAos dsRNA. The combination of any of the above alterations and exposure to cold temperatures (between approximately 7° C. and approximately 15° C. or between approximately 10° C. and approximately 15° C.; approximately 8 hours per day) for approximately two weeks or more result in production of increased amounts of rubber than produced by the non-altered plant exposed to the same temperatures for the same time period.
- Many techniques involving molecular biology discussed herein are well-known to one of ordinary skill in the art and are described in, e.g., Green and Sambrook, Molecular Cloning, A Laboratory Manual 4th ed. 2012, Cold Spring Harbor Laboratory; Ausubel et al. (eds.), Current Protocols in Molecular Biology, 1994—current, John Wiley & Sons; and Kriegler, Gene Transfer and Expression: A Laboratory Manual (1993). Unless otherwise noted, technical terms are used according to conventional usage. Definitions of common terms in molecular biology maybe found in e.g., Benjamin Lewin, Genes IX, Oxford University Press, 2007 (ISBN 0763740632); Krebs, et al. (eds.), The Encyclopedia of Molecular Biology, Blackwell Science Ltd., 1994 (ISBN 0-632-02182-9); and Robert A. Meyers (ed.), Molecular Biology and Biotechnology: a Comprehensive Desk Reference, VCH Publishers, Inc., 1995 (ISBN 1-56081-569-8).
- The terms “approximately” and “about” refer to a quantity, level, value or amount that varies by as much as 30% in one embodiment, or in another embodiment by as much as 20%, and in a third embodiment by as much as 10% to a reference quantity, level, value or amount. As used herein, the singular form “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise. For example, the term “a bacterium” includes both a single bacterium and a plurality of bacteria.
- The term “nucleic acid consisting essentially of”, “polynucleotide consisting essentially of”, and “RNA consisting essentially of”, and grammatical variations thereof, means a polynucleotide that differs from a reference nucleic acid sequence by 20 or fewer nucleotides and also perform the function of the reference polynucleotide sequence. Such variants include sequences which are shorter or longer than the reference nucleic acid sequence, have different residues at particular positions, or a combination thereof.
- Having now generally described this invention, the same will be better understood by reference to certain specific examples and the accompanying drawings, which are included herein only to further illustrate the invention and are not intended to limit the scope of the invention as defined by the claims. The examples and drawings describe at least one, but not all embodiments, of the inventions claimed. Indeed, these inventions may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements.
- To better understand the role of PaAos in rubber synthesis, genetically altered P. argentatum plants are generated in which either PaAos is over-expressed or PaAos is silenced by RNAi. The various plasmids used to achieve the overexpression or silencing of PaAos in guayule are shown in
FIG. 1 . To generate these plasmids, the guayule Aos (PaAos) is amplified by PCR using genomic DNA as a template. The primers used to amplify PaAos are designed from the cDNA PaAos sequence published in NCBI database (GeneBank accession no. X78166.2) and have the following sequences:forward primer 5′-cttaagaggtggtATGGACCCATCGTCTAAACCC-3′ (SEQ ID NO: 1) andreverse primer 5′-ggatccTCATATACTAGCTCTCTTCAGGG-3′ (SEQ ID NO: 2). The nucleotides in lower case and underlined in the forward primer are the recognition nucleotides for restriction enzyme AflII; the nucleotides in lower case and underlined in the reverse primer are the recognition nucleotides for restriction enzyme BamHI. The PCR cycle program is the following: 94° C. for 2 minutes (initial heating step) and PaAos is amplified at 40 cycles of 94° C. for 30 seconds (denaturation), 71° C. for 30 seconds (annealing) and 68° C. for 1 minute (extension) and an additional 5 minutes extension at 68° C. The resulting amplicon is purified and subcloned into pGEM T Easy vector (Promega, Madison, Wis.) using manufacturer's recommended protocol and sequenced to confirm the sequence of the plasmids. The cDNA sequence is in SEQ ID NO: 9 and the amino acid sequence is in SEQ ID NO: 10. Subsequently, the PaAos amplicon is cut using AflII and BamHI. Plasmid pND6 has a Nos promoter driving the NPTII gene for conferring kanamycin resistance and a potato ubiquitin promoter (Garbarino and Belknap, Plant Mol. Biol. 24:119-127 (1994)) controlling the GUSplus gene (CambiaLabs, Canberra, Australia). SeeFIG. 1 . Plasmid pND6-Aos (FIG. 1 ) is generated by replacing the GUSplus gene in pND6 with cDNA PaAos sequence (SEQ ID NO: 9). Plasmid pND6-AosiL (FIG. 1 ) is generated by replacing the GUSplus gene in pND6 with an inverted repeat of a partial cDNA PaAos sequence (SEQ ID NO: 11) containing a loop sequence of the Bar gene between the inverted repeat of the partial cDNA PaAos sequence; the complete sequence replacing GUSplus is SEQ ID NO: 26. The plasmids pND6, pND6-AosiL, and pND6-Aos are used to transform Agrobacterium EHA101 competent cells using the protocol described in Hood, et al., J. Bacteriol. 168:1291-1301 (1986). - The transformed Agrobacterium EHA101 either harboring pND6, pND6-AosiL, or pND6-Aos are used to transform guayule G7-11 using the protocols set forth below. See also Dong, et al. (2006) and Dong, et al., Industrial Crops and Products 46:15-24 (2013). For Agrobacterium transformation, the overnight Agrobacterium culture are prepared by inoculating 50 μL glycerol stock into a 50 mL Falcon tube containing 5 mL LB medium plus 40 mg/L rifampcin and 200 mg/L spectinomycin, and shaking at 200 rpm at 28° C. The suspension then is centrifuged for 15 minutes at 1600×g at room temperature. The supernatant is discarded, and the pellet is re-suspended in 25 mL of inoculation solution ( 1/10 MS salts plus BA (2 mg/L), NAA (0.5 mg/L), glucose (10 g), acetosyringone (200 μM), pluronic F68 (0.05%), pH=5.2 (PhytoTechnology Labs, Shawnee Mission, Kans.)). For leaf transformation, leaf sections are cut from the plants in the Magenta boxes (Caisson Labs, Smithfield, Utah). The adaxial side of each leaf is placed facing up in a Petri dish containing 5 ml Agrobacterium suspension. The leaf is cut into ˜10 mm strips and immediately placed in an empty Petri dish in non-overlapping manner. When this Petri dish is full, all leaf strips are blotted with the filter paper and placed into another empty Petri dish. The Petri dish is sealed by parafilm and left in the dark at room temperature. The co-cultivation is replaced by this co-desiccation according to Cheng, et al., In Vitro Cell Dev. Biol. Plant, 39, 595-604 (2003). After three days, leaf strips are transferred to MSB1T (MS medium with BA (1 mg/L), sucrose (30 g/L), phytagel (3 g/L), and timentin (400 mg/L)) (Cheng, et al., Plant Cell Rep., 17(8):646-649 (1998)) for recovery at low light for 5 days. The leaf strips are then transferred to MSB1TK30 (MS medium containing BA (1 mg/L), sucrose (30 g/L), phytagel (3 g/L), timentin (250 mg/L), and kanamycin (30 mg/L)) for selection under low light for two weeks. The leaf strips are then subcultured every 2 weeks under high light till green shoots emerged. Green shoots 10 mm and longer are transferred to ½MS10.1TK10 for rooting (same as ½MSI0 but with timentin (250 mg/L) and kanamycin (10 mg/L)). After 2-4 weeks, the rooted plantlets are micropropogated and subsequently transplanted into soil.
- While the genetically altered guayule are still growing in tissue culture under selection, the genetically altered plants are screened for integration of the expression vectors, pND6-Aos (PaAos in forward orientation; SEQ ID NO: 9), pND6-AosiL (PaAos in the reverse orientation (a portion of reverse complement of PaAos is SEQ ID NO: 11)), and pND6 (negative control). DNA is extracted from genetically altered plants using Sigma Kit (Sigma-Aldrich, St. Louis, Mo.). Approximately 150 mg leaf tissue (3 leaf tissues) are cut from the plants grown in tissue-cultured, placed into 2 mL tubes and snapped-frozen in liquid nitrogen. A bead is added to pulverize the tissue into a fine powder at a frequency of 30/s for 1 minute using the mixer mill MM 400 tissue lyser (Verder Scientific, Inc., Newtown, Pa.).
- PCR is carried out in 50 μL
mixture containing Taq 2× Master Mix (New England Biolabs, Ipswich, Mass.), 200 ng guayule genomic DNA or 20 pg plasmid DNA, and 100 ng of PaAos specific primers; namely SEQ ID NOs: 1 and 2 for guayule transformed with pND6-Aos; and SEQ ID NOs: 3 and 4 for guayule transformed with pND6-AosiL. SeeFIG. 2 . After heating the samples to 94° C. for 2 minutes, the reaction proceeds with 35 cycles of 94° C. for 30 seconds, 71° C. to amplify the PaAos in the overexpression lines (pND6-Aos) for 30 seconds or 56° C. for the PaAos in the RNAi lines (pND6-AosiL) for 30 seconds, and 68° C. for 1 minute. A final elongation step is carried out at 68° C. for 5 minutes. PCR products are separated by electrophoresis on a 1% (w/v) agarose gel. The band for the overexpression lines is at ˜1.4 kbp, as expected; the band for the RNAi lines is at ˜0.5 kbp as expected. The genetically altered guayule plants harboring the empty plasmid (pND6 (negative control)) are confirmed by GUS staining (Karcher, S., ABLE 23:29-42 (2002)). Briefly, plant tissues are placed in a 50 mL tube containing GUS assay solution (1 mM X-Gluc (5-bromo-4-chloro-3-indolyl) B-D-glucuronic acid in 50 mM Na2HPO4, pH 7.0 and 0.1% Triton X-100). The reaction is incubated at 37° C. for 1 hour followed by washing for 30 minutes with 70% ethanol to extract the chlorophyll. - Guayule containing intact PaAos (non-altered; G7-11) and genetically altered guayule containing one of the plasmids (pND6, pND6-Aos, or pND6-AosiL) are further screened to determine the RNA level (see Table 3). Leaves from the various genetically modified plants (which are grown in tissue culture) are collected and snap-frozen in liquid nitrogen for RNA extraction. RNA is extracted using TRIzol® according to manufacturer's recommended protocol (Ambion, Pittsburgh, Pa.). RNA concentration is quantified with the NanoDrop ND1000 (ThermoScientific, Wilminton, Del.). RNA cleanup is performed using the RNeasy MinElute Cleanup kit according to manufacturer's recommended protocol (Qiagen Inc., Valencia, Calif.). The RNA is eluted with 30-50 μL of RNase-free water along with on-column DNase1 treatment.
- Using the RNA isolated from the leaves of the genetically altered plants, cDNA is generated using iScript cDNA synthesis kit (Bio-Rad, Hercules, Calif.) according to the manufacturer's recommended protocol for semi-quantitative PCR and real-time quantitative PCR (qRT-PCR). An amount of 1 μg of RNA is used in the 20 mL reaction mixture. For qRT-PCR, 2 μL of the diluted cDNA (1:20) is used in a 15 μL reaction mixture. In the qRT-PCR volume, 7.5 mL of iQ SYBR® Green Supermix is used (Bio-Rad, Hercules, Calif.). The qRT-PCR is run using the 7500 Fast Real-Time PCR system (Applied Biosystem, Waltham, Mass.) with the following thermal cycle: 95° C. pre-incubation for 3 minutes; amplification is performed for 40 cycles at 95° C. for 15 seconds and at 60° C. for 30 seconds; the dissociation stage is set for 95° C. for 15 seconds, at 60° C. for 1 minute, and at 95° C. for 15 seconds. Each qRT-PCR run is performed with three independent tissue samples, each sample having two technical replicates. The 18S gene (˜200 bp) is used as an internal control. The primers used for each sequence, PCR reaction conditions, and the expected amplicon size are contained in
FIG. 2 . Crossing point value, which is the point at which the fluorescence crosses the threshold, and melting curve analyses are noted. The melting curve data are collected for all genes to ensure a single peak, indicating amplification of a specific region by a pair of primers. The relative expression values are calculated using the 2(-Delta C(T)) method (Livak and Schmittgen, Methods, 25:402-408 (2001)). See Table 3 below. -
TABLE 3 P. argentatum Average Relative Genotypes Expression of Aos G7-11 1.02 ± 0.2 pND6-10 1.14 ± 0.2 pND6-12 1.02 ± 0.3 pND6-29 1.04 ± 0.2 pND6-32 1.00 ± 0.3 pND6-33 1.11 ± 0.3 pND6-35 0.90 ± 0.2 pND6-41 0.91 ± 0.2 pND6-AosiL5-1 0.39 ± 0.1* pND6-AosiL7-2 0.49 ± 0.1* pND6-AosiL8-1 0.53 ± 0.1* pND6-AosiL9-15 0.44 ± 0.1* pND6-AosiL9-16 0.37 ± 0.04* pND6-AosiL12-1 0.55 ± 0.1* pND6-AosiL12-3 0.48 ± 0.1* pND6-AosiL13-2 0.55 ± 0.05* pND6-AosiL15-3 0.36 ± 0.1* pND6-AosiL15-4 0.48 ± 0.2* pND6-Aos4-1 2.15 ± 0.1** pND6-Aos4-2 2.11 ± 0.3** pND6-Aos5-1 2.29 ± 0.4** pND6-Aos7-1 2.40 ± 0.6** pND6-Aos7-3 2.11 ± 0.2** pND6-Aos8-2 2.15 ± 0.2** pND6-Aos10-1 2.44 ± 0.7** pND6-Aos10-2 2.12 ± 0.4** pND6-Aos11-5 2.30 ± 0.3** pND6-Aos14-2 2.23 + 0.1** G7-11 = wild-type control; pND6 = empty vector (pND6 without Aos); pND6-AosiL = PaAos is knocked-down/silenced; pND6-Aos = PaAos is over-expressed Results are average of three independent plants, each plant having three technical replicates. * and ** indicate significant difference in comparison to G7-11 guayule and/or pND6 (controls) at p > 0.05 and 0.005, respectively. - Next, to gain more insight as to where the PaAos is spatially located, the expression pattern of PaAos in various guayule tissues is analyzed using qRT-PCR. Total RNA is extracted from leaves, petiole, stem, root, young flower, mature flower, peduncle, stembark of 8-week-old tissue-cultured genetically altered plants as well as 2-month-old greenhouse grown genetically altered plants using the protocol described above. qRT-PCR is performed as described above on these samples of total RNA. Primers (SEQ ID NOs: 7 and 8 in
FIG. 2 ) are designed to amplify ˜200 bp PCR product in PaAos coding sequence. The expression level for each tissue are compared to the tissue cultured and greenhouse leaf tissues, respectively. The 18S gene (˜200 bp) (forward primer is SEQ ID NO: 5 and reverse primer is SEQ ID NO: 6, described supra and inFIG. 2 ) is used as an internal control. As shown in Table 4, infra, the largest level of PaAos expression is present in the stem, root and stembark tissues, suggesting that these tissues are sites in which PaAos is functioning. -
TABLE 4 Growth Conditions: MS Medium Greenhouse Tissue Source Relative Expression Leaf 0.98 ± 0.1 1.04 ± 0.2 Petiole 0.31 ± 0.06 0.41 ± 0.1 Stem 2.27 ± 0.2 3.37 ± 0.4 Root 2.47 ± 0.2 3.74 ± 0.3 Young Flower no data 1.23 ± 0.4 Mature Flower no data 0.69 ± 0.2 Peduncle no data 0.25 ± 0.1 Bark no data 4.49 ± 1.2 The error bars represent tissues collected from 3 individual plants. - Rooted plantlets (genetically altered, empty vector transformed (pND6 without PaAos), and wild-type control) from transferred shoot tips are grown on half-strength MS medium (PhytoTechnology Laboratories, Overland Park, Kans.) in Magenta boxes (Caisson Labs, Smithfield, Utah) for 6 weeks. The top part of the plantlets are separated from the medium and lyophilized for 48 hours. The dried tissues are placed in a 50 mL stainless steel grinding jar containing grinding ball, frozen in liquid nitrogen for 5 minutes and finely ground using the Retsch mixer mill MM 400 at a frequency of 30/second for 1 minute (Verder Scientific Inc., Newtown, Pa.). Three hundred milligrams (0.3 g) of pulverized tissues are partitioned with Ottawa sand (Fisher Scientific, Fair Lawn, N.J.) and loaded into 11 mL stainless steel extraction cells (Dionex, Sunnyvale, Calif.). Three sequential extractions are performed using the Accelerated Solvent Extractor (ASE 2000; Dionex, Sunnyvale, Calif.): 1. Acetone: to remove resinous material and the low molecular weight organic solubles; 2. Methanol: to remove chlorophyll and other alcohol-soluble materials; 3. Cyclohexane: to remove rubber. Natural rubber is quantified gravimetrically. The percent (%) rubber is the amount (% dw) of cyclohexane extract from 0.3 g dried tissue. The pND6-AosiL plants have 1.5 to 2 times more rubber than G7-11, pND6 and pND6-Aos in tissue-cultured environment (Table 5). In Table 5, the rubber content is quantified from leaf and stems of the indicated guayule genotypes grown in MS media.
-
TABLE 5 Rubber content of guayule plant shoots determined by Accelerated Solvent Extraction P. argentatum Genotypes Average Rubber Content (%) G7-11.1 1.01 ± .01 G7-11.2 1.11 ± .02 pND6-12 1.13 ± 0.2 pND6-33 1.10 ± 0.1 pND6-35 1.04 ± 0.2 pND6-AosiL5-1 1.8 ± 0.1* pND6-AosiL7-2 2.0 ± 0.3** pND6-AosiL8-1 2.1 ± 0.04*** pND6-AosiL8-2 1.7 ± 0.1** pND6-AosiL9-15 1.7 ± 0.02** pND6-AosiL9-16 2.3 ± 0.4* pND6-AosiL12-1 2.46 ± 0.3* pND6-AosiL12-3 1.62 ± 0.002*** pND6-Aos4-1 0.96 ± 0.2 pND6-Aos4-2 0.85 ± 0.1 pND6-Aos5-1 1.09 ± 0.1 pND6-Aos5-2 1.23 ± 0.1 pND6-Aos7-1 0.96 ± .02 pND6-Aos8-2 1.23 ± 0.1 pND6-Aos11-5 1.23 ± 0.1 Note: The rubber content is quantified from shoots (leaves + stems) of guayule genotypes grown in MS media. Error bars represent three biological plants with three technical replicates each. *, ** and *** indicate significant difference in comparison to G7-11 guayule and/or pND6 (controls) at p > 0.05, 0.005 and 0.0005, respectively. - Next, the genetically altered guayule plants are transplanted into soil and grown for 2 months under 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h) in growth chamber conditions, representing a microcosm of what guayule plants experience in the field during winter. Under these conditions, pND6-AosiL plants also exhibited elevated rubber content, having up to 31% times more rubber in comparison with G7-11, pND6 and pND6-Aos plants (Table 6). In Table 6, the rubber content is quantified from shoots and roots of the indicated guayule genotypes grown in soil. These plants are approximately 4 months old when rubber content is analyzed (tissue culture (approx. 1.5 months), greenhouse (approx. 1 month), and growth chamber (approx. 2 months)).
-
TABLE 6 Rubber content of guayule plant tissue determined by Accelerated Solvent Extraction Average Rubber Content (%) Shoot Root P. argentatum 27° C. (16 h)/ 27° C. (16 h)/ 27° C. (16 h)/ 27° C. (16 h)/ Genotypes 25° C. (8 h) 10° C. (8 h) 25° C. (8 h) 10° C. (8 h) G7-11.1 1.22 + 0.09 1.13 + 0.11 1.10 + 0.04 0.95 + 0.10 G7-11.2 1.06 + 0.12 1.37 + 0.09 0.63 + 0.12 0.71 + 0.09 pND6-12 1.04 + 0.18 1.31 + 0.06 0.65 + 0.07 0.72 + 0.16 pND6-33 0.90 + 0.06 1.14 + 0.12 0.62 + 0.08 0.82 + 0.10 pND6-35 1.18 + 0.08 1.27 + 0.10 1.09 + 0.06 0.94 + 0.03 pND6-AosiL7-2 1.49 + 0.07*** 1.86 + 0.11*** 0.56 + 0.03 1.26 + 0.09** pND6-AosiL8-1 1.48 + 0.05*** 1.91 + 0.07*** 0.78 + 0.14 1.19 + 0.04** pND6-AosiL9-16 1.46 + 0.04*** 2.01 + 0.08*** 0.66 + 0.12 1.16 + 0.02** pND6-AosiL12-1 1.55 + 0.07* 1.80 + 0.05** 1.26 + 0.04*** 1.52 + 0.07** pND6-Aos4-1 0.97 + 0.26 1.13 + 0.2 0.57 + 0.05 0.79 + 0.09 pND6-Aos4-2 1.21 + 0.10 1.30 + 0.08 1.05 + 0.10 0.94 + 0.11 pND6-Aos5-1 0.98 + 0.30 1.04 + 0.12 0.54 + 0.11 0.62 + 0.10 pND6-Aos7-1 0.96 + 0.30 1.15 + 0.14 0.57 + 0.06 0.55 + 0.08 Note: The rubber content is quantified from shoots and roots of guayule genotypes grown in soil. Plants are transferred to soil from tissue culture and are grown in a growth chamber environment. Error bars represent three biological plants with three technical replicates each. *, ** and *** indicate significant difference in comparison to G7-11 and/or pND6 (controls) at p > 0.05, 0.005 and 0.0005, respectively. - Because rubber is also accumulated in root tissue, the rubber content in the root tissues is also quantified. For the root rubber content, the consistent, significant difference is only under 27° C. (16 h)/10° C. (8 h) in which pND6-AosiL guayule have an increased in rubber content compared with the controls and pND6-Aos (Table 6). The data in Table 6 demonstrate that the combination of cold temperature and silencing PaAos is synergistic, causing guayule to produce a greater amount of rubber than guayule exposed to just cold temperature or to just PaAos silencing. For example, cold treatment alone increased shoot rubber content in the control (pND6-12) by 19%—from an average of 1.04% to 1.24%. But cold treatment of the Aos-downregulated plants (pND6-AosiL) increased rubber by 27%—from average 1.50% to 1.90%. In root tissues, cold treatment increased the rubber content for the control (pND6-12) by 5.1% (from 0.79 to 0.83% rubber), but cold treatment of the Aos-downregulated plants (pND6-AosiL) increased rubber by 57%—from average 0.82% to 1.28%. See Table 7, infra. From the ASE results, the increased in rubber content is very apparent in the pND6-AosiL genotypes.
-
TABLE 7 Average Rubber Content (%) Shoot Root 27° C. 27° C. 27° C. 27° C. P. argentatum (16 h)/ (16 h)/ (16 h)/ (16 h)/ Genotypes 25° C. (8 h) 10° C. (8 h) 25° C. (8 h) 10° C. (8 h) pND6-12 1.04 1.24 0.79 0.83 pND6-AosiL7-2 1.50 1.90 0.82 1.28 pND6-Aos4-1 1.03 1.16 0.68 0.73 - Guayule washed rubber particles (WRPs) are isolated from genetically altered guayule lines (pND6-AosiL and pND6-Aos) and non-altered guayule using the protocol set forth in Cornish and Backhaus, Phytochemistry, 29: 3809-3813 (1990). Rubber particles are extracted from non-altered and genetically altered 1 year old greenhouse plants. First, ˜60 g to ˜70 g of stembark tissues are peeled off from the plant, grounded with a blender containing cold-extraction buffer, and further purified with cold-washed buffer three times by centrifugation. The protein extracts (1 mg) are run on an SDS-PAGE and detected with silver staining. On the SDS-PAGE gel, endogenous Aos protein runs as ˜53 kDa in the non-altered and overexpressed plants but not in the RNAi lines. To determine the dry weight of the WRPs, 50 μL of the protein extracts are aliquoted 3× on a weighing paper, oven-dried over-night in a 60° C. incubator and weighed the next day. Generally, approximately 0.5 mg/μL to approximately 1.5 mg/μL WRPs are extracted.
- PaAos is an enzyme in the biosynthetic pathway that produces several different plant hormones, including jasmonic acid, SA, abscisic acid, gibberellin A20, gibberellin A1, and gibberellin A3. As such, the amount of these hormones is quantified in genetically altered (pND6-AosiL and pND6-Aos), empty vector transformed (pND6 without PaAos; control), and wild-type (G7-11, control) tissue-cultured guayule plants using the protocol described in Pan et al., Nature Protocols 5:986-992 (2010). See Table 8, infra. Briefly, leaves and stems are snap-frozen and ground to powder with mortar and pestle. Solvent extraction solution containing 2-propanol/H2O/concentrated HCl (2:1:0.002; vol/vol/vol) and internal standards are added to ˜50 mg of pre-weighed tissues. After solvent extraction, sample concentration and re-dissolution, 50 μL of the sample solution is placed into the liquid chromatography-tandem spectrometry (Agilent GC-MS 5977A; Agilent Technologies, Santa Clara, Calif.) for hormone analysis. Three biological plants, with three technical replicates of each plant, are used.
-
TABLE 8 Concentration (ng/gfw) P. argentatum Jasmonic Salicylic Abscisic Gibberellin Gibberellin Gibberellin Genotypes Acid Acid Acid A20 A1 A3 G7-11 5.36 ± 1.2 5.50 ± 0.8 11.01 ± 1.9 15.95 ± 0.7 9.95 ± 0.07 3.52 ± 0.2 pND6-12 1.57 ± 0.1 4.89 ± 0.6 7.05 ± 0.8 14.11 ± 1.2 12.39 ± 2.2 2.19 ± 0.01 pND6-33 4.76 ± 1.0 5.04 ± 0.1 7.24 ± 0.3 13.86 ± 2.6 12.70 ± 2.3 1.79 ± 0.09 pND6-35 1.96 ± 0.4 5.6 ± 0.5 7.10 ± 0.6 14.41 ± 1.2 14.65 ± 0.2 2.16 ± 0.3 pND6-AosiL7-2 0.57 ± 0.1** 9.51 ± 0.5* 4.71 ± 0.6* 9.63 ± 1.2* 5.13 ± 0.8* 0.86 ± 0.3* pND6-AosiL9-16 0.57 ± 0.01** 7.65 ± 0.2* 2.96 ± 0.3* 8.85 ± 2.1* 7.81 ± 0.2** 0.80 ± 0.3* pND6-AosiL12-1 0.68 ± 0.05** 9.65 ± 1.1* 3.64 ± 0.5* 10.59 ± 0.2* 6.75 ± 1.1* 1.32 ± 0.07* pND6-Aos4-1 1.48 ± 0.2 4.03 ± 0.7 9.13 ± 1.71 15.49 ± 0.6 10.78 ± 0.1 1.93 ± 0.06 pND6-Aos4-2 3.25 ± 0.2 4.76 ± 0.6 13.9 ± 1.3 no data 14.63 ± 2.7 1.80 ± 0.1 pND6-Aos7-1 1.41 ± 0.3 5.50 ± 0.02 8.84 ± 0.3 13.64 ± 1.2 13.96 ± 0.01 1.84 ± 0.1 ± represent three biological plants with three technical replicates each plant. * and ** indicate significant difference in comparison to G7-11 and/or pND6 (controls) at p > 0.05 and 0.005, respectively. - As evident in Table 8, the amount of jasmonic acid, abscisic acid and gibberellic acids are reduced in the pND6-AosiL guayule compared to the amount in the controls (wild-type (G7-11) and empty vector transformed plants) and pND6-Aos guayule. Conversely, the SA content is elevated in pND6-AosiL compared to the controls and pND6-Aos lines. These results suggest that knocking down PaAos expression not only reduces production of jasmonic acid but also affects the level of other hormones as well.
- Three independent events from each of the overexpression (pND6-Aos) and of the silenced (pND6-AosiL) lines; as well as two pND6 and one wild-type (G7-11) controls are selected for further studies. pND6-AosiL plants grown in greenhouse (data not shown) and growth chamber conditions are bigger (see
FIG. 3 ), have darker green leaves (data not shown), and increased chlorophyll measurement than the wild type and other genetically altered plants (seeFIG. 4 ). As demonstrated inFIG. 3 , under 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h) environments, pND6-AosiL plants are significantly taller and wider in both conditions. These plant architectural traits reflect the fact that pND6-AosiL plants are larger and have more shoot and root biomass. - pND6-AosiL genotypes have also a greater number of stems than the wild-type and empty vector controls. Well-branched guayule plants are an indicator of having increased rubber yield because of the presence of more sink tissue available to store rubber. Additionally, the mature stembark tissues in pND6-AosiL have thicker diameter (ranging from approximately 35% to approximately 54%) under both 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h) in comparison to the controls and pND6-Aos. See
FIG. 5 . - Based on this observation, the photosynthetic rate of the plants is measured using LI-COR 6400xt (LI-COR Biosciences, Lincoln, Nebr.) to measure the photosynthetic rate. Measurements are taken between 0900 to 1200 h. Fully expanded middle leaf are clamped on the Li-Cor head. After the measured and set parameters are stabilized, the reading is taken. The middle leaf position is chosen because this position shows significant differences based on chlorophyll meter measurements,
FIG. 4 . (SPAD-502; Minolta Camera Ltd., Japan). The pND6-AosiL plants exhibit higher photosynthetic rate (23-31%) in comparison to G7-11, pND6 and pND6-Aos plants (Table 9, infra). Additional physiological measurements reveal that pND6-AosiL stomatal limitation is one of the factors involved in the higher photosynthetic rate as pND6-AosiL plants show higher stomatal conductance and transpiration rate when compared to G7-11, pND6 and pND6-Aos plants (Table 9, infra). Furthermore, chlorophyll fluorescence measurements clearly show PSII and ETR parameters used for elucidating the efficiency of PSII are significantly higher than G7-11, pND6 and pND6-Aos plants (Table 9, infra) in both 27° C. (16 h)/25° C. (8 h) and 27° C. (16 h)/10° C. (8 h) treatment conditions. Having higher PSII and ETR indicate that amount of light energy absorbed and carbon assimilated is available more in pND6-AosiL plants to convert into energy for the plant to use (i.e., growth and development as well as rubber production) compared to the controls and pND6-Aos plants. Meanwhile, the NPQ measurements for the pND6-AosiL plants are lower under the 27° C. (16 h)/25° C. (8 h) condition and higher under the 27° C. (16 h)/10° C. (8 h) treatment in comparison with the controls and pND6-Aos plants. Having higher NPQ suggests that pND6-AosiL have improved heat dissipation ability compared to G7-11, pND6 and pND6-Aos plants which could help prevent lipid or other cell membrane damage under environmental stress. -
TABLE 9 P. argentatum Genotypes Pn g € ΦPSII ETR NPQ 27° C. (16 h)/25° C. (8 h) G7-11 5.75 ± 0.8 0.093 ± 0.03 2.33 ± 0.6 0.146 ± 0.015 115.73 ± 11.3 1.97 ± 0.2 pND6-10 6.29 ± 0.7 0.110 ± 0.03 2.74 ± 0.6 0.141 ± 0.015 111.1 ± 11.6 1.74 ± 0.1 pND6-12 6.20 ± 0.8 0.109 ± 0.02 2.66 ± 0.5 0.145 ± 0.015 114.4 ± 12.1 1.90 ± 0.2 pND6-AosiL7-1 8.56 ± 0.6*** 0.147 ± 0.01*** 3.41 ± 0.3*** 0.196 ± 0.027* 165.2 ± 10.7*** 1.33 ± 0.2*** pND6-AosiL8-1 8.40 ± 0.6*** 0.155 ± 0.02*** 3.67 ± 0.4*** 0.180 ± 0.008* 141.4 ± 6.2** 1.27 ± 0.2*** pND6-AosiL9-16 7.96 ± 0.5*** 0.162 ± 0.03*** 3.57 ± 0.5*** 0.186 ± 0.018* 134.4 ± 3.3** 1.19 ± 0.3*** pND6-Aos4-1 5.62 ± 0.9 0.110 ± 0.04 2.59 ± 0.7 0.133 ± 0.008 104.7 ± 6.7 1.92 ± 0.3 pND6-Aos5-1 5.70 ± 0.8 0.110 ± 0.04 2.60 ± 0.7 0.133 ± 0.008 104.7 ± 6.7 1.95 ± 0.3 pND6-Aos7-1 5.87 ± 0.9 0.113 ± 0.04 2.65 ± 0.7 0.137 ± 0.008 107.7 ± 6.3 2.07 ± 0.4 27° C. (16 h)/10° C. (8 h) G7-11 2.23 ± 0.5 0.054 ± 0.02 1.31 ± 0.4 0.070 ± 0.007 55.4 ± 5.4 1.58 ± 0.2 pND6-10 2.04 ± 0.4 0.057 ± 0.02 1.55 ± 0.3 0.064 ± 0.006 50.7 ± 4.9 1.56 ± 0.2 pND6-12 2.28 ± 0.4 0.065 ± 0.03 1.67 ± 0.7 0.066 ± 0.003 51.6 ± 2.7 1.51 ± 0.3 pND6-AosiL7-1 4.14 ± 0.4*** 0.104 ± 0.02*** 2.54 ± 0.4*** 0.104 ± 0.011*** 81.0 ± 8.2*** 2.29 ± 0.3** pND6-AosiL8-1 4.15 ± 0.4*** 0.112 ± 0.05*** 2.71 ± 0.8*** 0.102 ± 0.013*** 77.0 ± 4.5*** 2.33 ± 0.2** pND6-AosiL9-16 4.14 ± 0.6*** 0.101 ± 0.03*** 2.60 ± 0.5*** 0.101 ± 0.009*** 79.4 ± 6.9*** 1.95 ± 0.1** pND6-Aos4-1 2.27 ± 0.5 0.059 ± 0.02 1.51 ± 0.3 0.065 ± 0.011 60.4 ± 5.5 1.35 ± 0.3 pND6-Aos5-1 2.97 ± 0.3 0.069 ± 0.01 1.81 ± 0.2 0.077 ± 0.007 58.5 ± 6.3 1.25 ± 0.2 pND6-Aos7-1 2.45 ± 0.6 0.063 ± 0.01 1.93 ± 0.3 0.065 ± 0.010 50.1 ± 5.8 1.44 ± 0.2 Pn = net photosynthetic rate; g = stomatal conductance; € = Transpiration rate; ΦPSII = Efficiency of Photosystem II; ETR = Electron Transport Rate; NPQ = Non-photochemical quenching *, ** and ***indicate significant difference in comparison to G7-11 and/or pND6 (controls) at p > 0.05, 0.005 and 0.0005, respectively. - The length of the polymer chain, a.k.a. rubber molecular weight, is the primary determinant of quality in natural rubber. Gel permeation chromatography (GPC) is used to measure the molecular weight of rubber from guayule tissue culture plants' extracts. Cyclohexane extractables collected from ASE (see Example 3 and Table 5 supra) are re-suspended in approximately 3 mL of tetrahydrofuran (THF) overnight with gentle shaking (Multi-Purpose Rotator. Thermo Scientific, Waltham. Mass.). The solution is syringe-filtered through a 1.6 μm glass microfiber GF/A filter (Whatman GE Healthcare, Piscataway, N.J.), then injected into a Hewlett Packard 1100 series HPLC (1.0 mL/min flow rate, 50 μL injection volume, THF continuous phase) and size exclusion separated by two
Agilent PL gel 10 μm Mixed-B columns in series (35° C.) (Santa Clara, Calif.). The resulting chromatograms are used to calculate the rubber molecular weight shown inFIG. 6 (using Astra software (Wyatt Technology Corp., Santa Barbara, Calif.)). The molecular weight of natural rubber from three pND6-AosiL transformed guayule plants (silenced) is greater than from wild-type guayule line G7-11, two negative control pND6 transformed guayule plants and three pND6-Aos transformed guayule plants (overexpressed) indicating better quality rubber in the PaAos silenced guayule plants. InFIG. 6 , the asterisks (*) and (**) above the three pND6-AosiL transformed guayule plant lines indicate significant difference in comparison to the negative control pND6 transformed guayule plant lines at p>0.05 and p>0.005, respectively. - Eight different guayule cultivars grown in tissue culture are evaluated for their rubber content and expression of PaAos gene. The combination of ASE method (see Example 3 supra) and qRT-PCR (see the protocols and primers discussed in Example 2, supra, and
FIG. 2 ) are used to compare rubber content to the level of PaAos gene expression. First, seeds from guayule lines (PI 478648, W6 549, PI 478651,PI 478652, PI 478653, PI 478654, PI 478655, and PI 478662) are obtained from a public germplasm bank (USDA-ARS National Plant Germplasm System, Parlier, Calif.). The seeds are germinated and plants grown in tissue culture medium for 8 weeks. The natural rubber content is determined by standard methods, as described previously (ASE). The rubber content varied significantly between lines, from 0.95% to 1.73% (Table 10). Cultivar (line) W6 549 has the lowest average rubber content (%) andcultivar PI 478652 has the largest average rubber content (%) (see Table 10). -
TABLE 10 P. argentatum Germplasm Genotypes name Average Rubber Content (%) PI 478648 11635 1.38 ± 0.08 W6 549 CAL 70.95 ± 0.03 PI 478651 11701 1.40 ± 0.13 PI 47865212229 1.73 ± 0.28 PI 478653 12231 1.36 ± 0.11 PI 478654 N396 1.20 ± 0.05 PI 478655 N565 0.98 ± 0.01 PI 478662 A48118 1.07 ± 0.06 - PaAos gene expression for cultivars W6 549 and
PI 478652 are determined by standard methods (qRT-PCR, see Example 2, supra). Shoot tissues (leaf and stem) are collected into 2 mL tubes and are snap-frozen in liquid nitrogen and then hand pulverized (mortar and pestle). RNA is extracted using the TRIzol® method (Ambion, Pittsburgh, Pa.) using manufacturer's recommended protocol. The RNA concentration is quantified with the NanoDrop ND1000 (ThermoScientific, Wilmington, Del.). An RNA cleanup is performed using RNeasy MinElute Cleanup kit using manufacturer's recommended protocol (Qiagen Inc., Valencia, Calif.). The RNA is eluted with 30-50 tit of RNase-free water along with on-column DNase1 treatment. - An iScript cDNA synthesis kit (Bio-Rad, Hercules, Calif.) is used to synthesize complementary DNA (cDNA) from the isolated RNA. An amount of 1 μg of RNA is used in the 20 mL reaction mixture. For semi-qRT-PCR, 2 μL of the diluted cDNA (1:20) is used in a 50 μL reaction mixture of One Taq Quick-
Load 2× Master Mix with Standard Buffer (New England Biolabs, Inc., Ipswich, Mass.) with the following forward and reverse primers (10 μM) 5′-ATGGACCCATCGTCTAAACCC-3′ (SEQ ID NO: 16) and 5′-TCATATACTAGCTCTCTTCAGG-3′ (SEQ ID NO: 17), respectively. The semi-qRT-PCR is run using Eppendorf thermocyler (ThermoFisher Scientific, Waltham, Mass.) with the following thermal cycle: 94° C. pre-incubation for 30 seconds; amplification for 35 cycles at 94° C. for 30 seconds, annealing at 58° C. for 1.5 minutes, and extension at 68° C. for 1 minute. The final extension time is for 5 minutes at 68° C. Each semi-qRT-PCR run is performed with three independent tissue samples. The 18S gene (˜200 bp) is used as an internal control using SEQ ID NO: 5 as forward primer and SEQ ID NO: 6 as reverse primer. PCR products (˜1.4 Kbp) are separated by electrophoresis on a 1% (w/v) agarose gel. Results clearly demonstrate that W6 549 (“W6549”) cultivar has increased PaAos expression compared to PI 478652 (“478652”) cultivar (seeFIG. 7 ). These results suggest that the rubber content is inversely correlated with the PaAos gene expression. - PaAos coding sequence in the two lines, W6 549 cultivar (low rubber producer) and
PI 478652 cultivar (high rubber producer) are determined by PCR, and the sequences are compared to G7-11 cultivar sequence. Extraction of the cDNA from the agarose gel is performed with QIAquick Gel Extraction kit (Qiagen, Germantown, Md.) using manufacturer's recommended protocol. The 1.4 kb band visualized with ethidium bromide is excised from the gel with a clean razor blade. After determining the weight of the gel slice, 300 μl of Buffer QG pH 7.5 is added for every 100 mg of gel slice with the DNA fragment size of 100 bp-4 kb. To bind the DNA, 30 μl QIAEX II beads are added per 5 μg of DNA. The resuspended gel is dissolved by incubation at 50° C. for 10 minutes with vigorous vortexing every 2 minutes. Each sample is centrifuged at 16,110×g in a conventional table top microcentrifuge for 30 seconds. After centrifugation, each sample rests at room temperature for five minutes. The supernatant is discarded, and the pellet is washed with cold 750 μl Buffer PE twice. The pellet is air dried until it turned solid white. The DNA is resuspended with 50 μl of 10 mM of Tris-Cl pH 8.5. The dissolved DNA pellet stands at room temperature for 1 minute prior to centrifugation. The supernatant is collected as the purified cDNA product. To confirm the integrity of the sequence, three independent PCR products are sent to Elim Biopharmaceuticals (Hayward, Calif.) for analysis. The sequence alignment is performed using softwares MEGA 6.06 (Tamura, et al., Mol. Bio. and Evol., 30:2725-2729 (2013)) and T-Coffee (Notredame, et al., J. Mol. Biol., 302:205-217 (2000)). As evident inFIGS. 8A-8C , a few SNPs exist which give rise to changes in the amino acid sequences (seeFIG. 9 ). In particular, the amino acids at positions 318, 408 and 459 are D, I and L in W6 549 (“W6549”) cultivar while PI 478652 (“478652”) cultivar has N, V and W, respectively (FIG. 9 ). These differences in three amino acids result in different PaAos functionality which result in different amounts of rubber being produced. - By reducing PaAos' functionality, one increases rubber production in guayule. As discussed previously, reducing the amount of PaAos by silencing PaAos expression or translation increases rubber production. Null mutations (such as, but not limited to, insertions that disrupt translation of a functional protein, changing slice site recognition nucleotide(s), and changing ATG initiation codon) alter the production of functional PaAos which result in an increase in rubber production. Alternations in PaAos' DNA sequence that result in specific amino acid changes within PaAos also increase rubber production. For example, DNA alterations that change PaAos sequence from D318, I408 and/or L459 (present in W6 549 cultivar, low rubber producer) to N318, V408 and W459 (present in
PI 478652 cultivar, high rubber producer) (or any other non-conservative amino acid for D318, I408, and/or L459) result in an increase in rubber production because of a decrease in PaAos functionality. In addition, altering PaAos' DNA sequence encoding S332, E336, R339, S359, and/or S411 to a sequence encoding non-conservative amino acids results in reducing PaAos' functionality and thus increasing rubber production. See, Pan, et al., J. of Bio. Chem., 273(29):18139-18145 (1998), contents of which are expressly incorporated by reference. - Based on these results from these assays, one can screen for the presence of particular SNPs in the PaAos gene in various guayule varieties at the seedling stage to determine if a particular guayule variety is a high rubber producer or low rubber producer. To screen guayule, one obtains a tissue sample from the guayule to be screened, isolates the sample's mRNA or total RNA, and conduct a PCR assay (regular PCR or RT-PCR or qRT-PCR) using PaAos primers that surround the nucleotides encoding amino acids N318, V408 and W459 to identify guayule plants encoding these amino acids which indicate that the guayule produces more rubber than a guayule not having these amino acids within PaAos. Guayule seedlings (plants that are between 2-4 weeks and 8-10 weeks post-germination) are screened. Alternatively, guayule plants that are approximately 2 or 3 months old can be screened. While any plant tissue can be used to conduct the SNP analysis, bark and leaves may be easier to sample than other tissue (such as roots). Using the two
primer pairs 5′-CCTACTCGACGCCAAGAG-3′ (forward, SEQ ID NO: 18) and 5′-TTCAGCTGAGCATGTCTAGGT-3′ (reverse, SEQ ID NO: 19) and 5′-GGCATTGTTGAAGTACATATGG-3′ (forward, SEQ ID NO: 20) and 5′-CCAAAGGAGACTCGCCTAATT-3′ (SEQ ID NO: 21), one determines if the seedling or plant contains D318, I408 and/or L459 (similar to G7-11 and W6 549 cultivars) and thus produces less rubber than a “high rubber producer” plant. Alternatively, using the twoprimer pairs 5′-CCTACTCGACGCCAAAAGC-3′ (forward, SEQ ID NO: 22) and 5′-CTTAAGTTGAGCATGTCTAGGTT-3′ (reverse, SEQ ID NO: 23) and 5′-GGCATTGTTGAAGTACGTATGG-3′ (forward, SEQ ID NO: 24) and 5′-CCCAAGGAGACTCGCCTA-3′ (reverse, SEQ ID NO: 25), one determines if the seedling or plant contains N318, V408 and/or W459 (similar toPI 478652 cultivar) and thus produces more rubber than a “low rubber producer” plant. Furthermore, guayule containing PaAos with S332, E336, R339, S359, and/or S411, in combination with one or more of D318, I408 and L459, are also low rubber producing plants. Primers are designed to cover the SNPs for these amino acids which are used to identify low rubber producing guayule. Similarly, guayule containing PaAos with non-conservative amino acids to D318, S332, E336, R339, S359, I408, S411, or L459, or a combination thereof, are high rubber producing plants, and primers are designed to cover the SNPs for these amino acids which are used to identify high rubber producing plants. After performing the PCR assay, one isolates the amplicon(s) and sequences the amplicon(s) to determine the presence or absence of the indicated SNPs. Other techniques are known to one of ordinary skill in the art for identifying amplicons with the indicated SNPs. - Alternatively, an ELISA or other type of antibody assay can distinguish between PaAos containing N318, V408 and/or W459 (
PI 478652 cultivar (high producer)) and PaAos containing D318, I408 and/or L459 (W6 549 cultivar (low producer)), with or without one or more of S332, E336, R339, S359, and S411. An ELISA using a monoclonal antibody (mAb) that is specific for PaAos containing N318, V408 and/or W459, with or without one or more non-conservative amino acids substituted for S332, E336, R339, S359, and S411, would identify high rubber producing plants. Alternatively, an ELISA using a mAb that is specific for PaAos containing D318, I408 and/or L459 with or without one or more amino acids S332, E336, R339, S359, and S411, would identify low rubber producing plants. Protein isolated from tissue sample, as described above, can be contacted with the mAb(s) in the ELISA which then changes color to indicate the presence of PaAos having the particular amino acids and structure to which the mAb binds. - Guayule encoding PaAos with conservative amino acid substitutions for N318, V408 and/or W459 (and optionally with non-conservative amino acid substitutions for S332, E336, R339, S359, and/or S411) are high rubber producing guayule. Similarly, guayule encoding PaAos with conservative amino acid substitutions for D318, I408 and/or L459 (and optionally with or without conservative amino acid substitutions for S332, E336, R339, S359, and/or S411) are low rubber producing guayule. See Table 2 and preceding paragraph for information about conservative and non-conservative amino acid substitutions, and Table 1 for DNA codons for amino acids.
- One can generate DNA mutations within guayule seed's genome using EMS, UV light, protons, or other known mutagens to create altered guayule seeds. Then one germinates the seeds into seedlings and screen the seedlings for PaAos mutations which reduce PaAos' functionality. In one embodiment, the above described primers are used to determine if the indicated SNPs are present in the altered guayule seedling so that one does not need to grow the altered guayule for years before determining if the altered guayule is likely a high rubber producer or a low rubber producer. One can screen for D318, S332, E336, R339, S359, I408, S411, and/or L459 and conservative amino acids to determine if the altered seedling is a low rubber producer; or screen for non-conservative amino acid substitutions to determine if the altered seedling is a high rubber producer.
- The foregoing detailed description and certain representative embodiments and details of the invention have been presented for purposes of illustration and description of the invention. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. It will be apparent to practitioners skilled in the art that modifications and variations may be made therein without departing from the scope of the invention. All references cited herein are incorporated by reference.
Claims (17)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/975,912 US20180327770A1 (en) | 2017-05-11 | 2018-05-10 | Guayule with increased rubber production and yield |
| EP18799406.6A EP3622067A4 (en) | 2017-05-11 | 2018-05-11 | Guayule with increased rubber production and yield |
| PCT/US2018/032214 WO2018209176A1 (en) | 2017-05-11 | 2018-05-11 | Guayule with increased rubber production and yield |
| MX2019013413A MX2019013413A (en) | 2017-05-11 | 2018-05-11 | Guayule with increased rubber production and yield. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762504762P | 2017-05-11 | 2017-05-11 | |
| US15/975,912 US20180327770A1 (en) | 2017-05-11 | 2018-05-10 | Guayule with increased rubber production and yield |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20180327770A1 true US20180327770A1 (en) | 2018-11-15 |
Family
ID=64096419
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/975,912 Abandoned US20180327770A1 (en) | 2017-05-11 | 2018-05-10 | Guayule with increased rubber production and yield |
| US15/975,851 Active 2038-12-20 US10982219B2 (en) | 2017-05-11 | 2018-05-10 | Guayule with increased rubber production and yield |
| US17/197,536 Abandoned US20210238619A1 (en) | 2017-05-11 | 2021-03-10 | Guayule with increased rubber production and yield |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/975,851 Active 2038-12-20 US10982219B2 (en) | 2017-05-11 | 2018-05-10 | Guayule with increased rubber production and yield |
| US17/197,536 Abandoned US20210238619A1 (en) | 2017-05-11 | 2021-03-10 | Guayule with increased rubber production and yield |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US20180327770A1 (en) |
| EP (2) | EP3622067A4 (en) |
| MX (2) | MX2019013413A (en) |
| WO (2) | WO2018209176A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117004752A (en) * | 2023-06-01 | 2023-11-07 | 云南省热带作物科学研究所 | Molecular marker primer and kit for identifying rubber tree cloud-ground 7346 and application |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020046144A1 (en) * | 2018-08-28 | 2020-03-05 | Synthase Biotech Limited | Novel enzymes |
| WO2025116748A1 (en) * | 2023-11-30 | 2025-06-05 | Lipoxagen Limited | Novel compositions and uses |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5633433A (en) | 1991-04-17 | 1997-05-27 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Rubber particle protein gene from guayule |
| US6132711A (en) | 1991-04-17 | 2000-10-17 | Arizona Board Of Regents | Enzymatic antioxidant of allene oxide for lipid peroxidation in biological systems |
| EP0675202A1 (en) | 1994-03-31 | 1995-10-04 | Arizona Board Of Regents | The rubber particle protein gene from guayule |
| US6541682B1 (en) | 1998-11-12 | 2003-04-01 | Calgene Llc | Plastid transformation of solanaceous plants |
| EP2281890A1 (en) | 2000-07-31 | 2011-02-09 | Danisco US Inc. | Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms |
| US6822142B2 (en) | 2001-01-05 | 2004-11-23 | Monsanto Company | Transgenic plants containing altered levels of steroid compounds |
| US7132590B2 (en) * | 2001-12-18 | 2006-11-07 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods of making male-sterile plants by underexpressing allene oxide synthase |
| US9018449B2 (en) | 2004-03-10 | 2015-04-28 | The United States of America, represented by The Secretary of Agiculture | Transformation methods for Guayule using Agrobacterium and reduced light to slow metabolism and enhance recovery |
| US8013213B2 (en) | 2004-11-24 | 2011-09-06 | The United States Of America As Represented By The Secretary Of Agriculture | Guayule plants, products, and derivatives |
| US9574203B1 (en) | 2012-11-08 | 2017-02-21 | The United States Of America, As Represented By The Secretary Of Agriculture | Transgenic guayule for enhanced isoprenoid production |
| US9523097B2 (en) | 2013-03-15 | 2016-12-20 | The United States Of America, As Represented By The Secretary Of Agriculture | Engineering rubber production in plants |
| WO2016161359A1 (en) * | 2015-04-03 | 2016-10-06 | The Regents Of The University Of California | Induction of latex accumulation in rubber-producing shrubs |
-
2018
- 2018-05-10 US US15/975,912 patent/US20180327770A1/en not_active Abandoned
- 2018-05-10 US US15/975,851 patent/US10982219B2/en active Active
- 2018-05-11 EP EP18799406.6A patent/EP3622067A4/en not_active Withdrawn
- 2018-05-11 MX MX2019013413A patent/MX2019013413A/en unknown
- 2018-05-11 EP EP18797996.8A patent/EP3622077A4/en active Pending
- 2018-05-11 MX MX2019013391A patent/MX2019013391A/en unknown
- 2018-05-11 WO PCT/US2018/032214 patent/WO2018209176A1/en not_active Ceased
- 2018-05-11 WO PCT/US2018/032229 patent/WO2018209184A1/en not_active Ceased
-
2021
- 2021-03-10 US US17/197,536 patent/US20210238619A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117004752A (en) * | 2023-06-01 | 2023-11-07 | 云南省热带作物科学研究所 | Molecular marker primer and kit for identifying rubber tree cloud-ground 7346 and application |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019013391A (en) | 2020-08-03 |
| WO2018209184A1 (en) | 2018-11-15 |
| MX2019013413A (en) | 2020-12-10 |
| US20210238619A1 (en) | 2021-08-05 |
| WO2018209176A1 (en) | 2018-11-15 |
| US10982219B2 (en) | 2021-04-20 |
| EP3622067A4 (en) | 2021-01-27 |
| EP3622077A1 (en) | 2020-03-18 |
| EP3622077A4 (en) | 2021-01-27 |
| EP3622067A1 (en) | 2020-03-18 |
| US20180327765A1 (en) | 2018-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3500666A1 (en) | Methods and compositions for short stature plants through manipulation of gibberellin metabolism to increase harvestable yield | |
| US10982225B2 (en) | Flowering time-regulating genes and related constructs and applications thereof | |
| US10793868B2 (en) | Plants with increased seed size | |
| WO2019161144A1 (en) | Methods and compositions for short stature plants through manipulation of gibberellin metabolism to increase harvestable yield | |
| CN111630171A (en) | plant lodging resistance | |
| CA3091251A1 (en) | Compositions and methods for improving crop yields through trait stacking | |
| WO2019161151A1 (en) | Compositions and methods for improving crop yields through trait stacking | |
| US20210238619A1 (en) | Guayule with increased rubber production and yield | |
| WO2019085961A1 (en) | Abiotic stress tolerant plants and polynucleotides to improve abiotic stress and methods | |
| CN108368518A (en) | The method for preparing monoploid and subsequent doubled haploid plant | |
| WO2019129145A1 (en) | Flowering time-regulating gene cmp1 and related constructs and applications thereof | |
| WO2015007241A1 (en) | Molecular marker | |
| CN105713079B (en) | Application of protein and related biomaterials in improving plant yield | |
| US20220298527A1 (en) | Compositions and methods for improving crop yields through trait stacking | |
| CN106279386B (en) | A rice panicle top growth and development-related protein, its coding gene and application | |
| WO2021003592A1 (en) | Sterile genes and related constructs and applications thereof | |
| CN112280786A (en) | A kind of high-efficiency nutrient utilization herbicide-tolerant corn even HH2823 transformation event and its specific identification method and application | |
| WO2013146171A1 (en) | Gene for shortening stalk of gramineous plant and method for producing short-stalked gramineous plant | |
| CN103172714A (en) | Rice leaf rolling-associated protein OsMYB103L as well as encoding gene and application thereof | |
| CN105566468A (en) | Plant fertility related protein and applications thereof | |
| CN116789785B (en) | FarL1, a high-yield and high-light-efficiency gene of long-stamen wild rice, and its application | |
| US10961541B2 (en) | Genetically altered guayule having increased rubber production and methods thereof | |
| CN109422802B (en) | Plant seed dormancy-related proteins and their encoding genes and applications | |
| CN117946232A (en) | Long stamen wild rice large spike high yield gene OlGn8.2 and application thereof | |
| WO2025042836A1 (en) | Methods and compositions for short stature plants through manipulation of gibberellin metabolism to increase harvestable yield |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: BRIDGESTONE CORPORATION, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DIERIG, DAVID A.;CRUZ, VONMARK V.;REEL/FRAME:045777/0109 Effective date: 20180511 |
|
| AS | Assignment |
Owner name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCMAHAN, COLLE M.;PLACIDO, DANTE;SIGNING DATES FROM 20180514 TO 20180516;REEL/FRAME:045820/0418 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |